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ABSTRACT 
E-selectin, an endothelial ceil adhesion molecule, is expressed on the 
surface of activated endothelial cells. Its role in neutrophil recruitment in acute 
murine inflammation, a previously undescribed entity, was the focus of this work. 
The interaction between P-selectin and E-seiectin in neutrophil extravasation was 
also investigated. 
Two murine models of acute inflammation were utilized in this work: acute 
pneumonitis induced by intranasal (IN) instillation of bacterial lipopolysaccharide 
(LPS) and chemical peritonitis Induced by intraperitoneal (IP) injection of 
thioglycollate broth. Intranasal LPS, a novel model, resulted in a progressive influx 
of neutrophils into the lungs begining near airways and extending into distant 
alveoli 4-6 hours later. Intraperitoneal thioglycollate is a model commonly used to 
examine the role of adhesion molecules in acute inflammation. 
E-selectin expression, which peaked 4-6 hours post-treatment, was 
immunohistochemicaily detected on the endothelium of scattered vessels in the 
lungs of mice following IN instillation of LPS. P-selectin was detected in 
endothelial cells in control mouse lungs and increased post-treatment with IN LPS. 
Blocking with anti-E-selectin MAb did not decrease the neutrophil count in 
the peritoneal cavity following IP injection of thioglycollate. Nor did these 
antibodies decrease the neutrophil count in the bronchoalveolar lavage of mice 2 
hours after IN instillation of LPS; whereas, by 6 hours post-treatment, there was a 
moderate decrease. However, when anti-P-selectin MAb were combined with the 
anti-E-selectin MAb, a significant increase in blocking was seen in the 6 hour 
group, demonstrating a redundancy in the function of these molecules. A 
V 
carbohydrate analog of the selectin ligand was unable to block neutrophil influx in 
either model. 
Transgenic mice deficient in the gene for E-selectin had no macro- or 
microscopic abnormalities when compared to wild-type mice. They did have 
slightly elevated numbers of neutrophils in circulating in blood. However, 
neutrophil numbers In the peritoneal lavage of E-selectin deficient mice were not 
different from wild-type mice after IP thioglycollate. In conclusion, the role of E-
selectin in acute murine inflammation is one which overlaps with P-selectin. 
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GENERAL INTRODUCTION 
Preamble 
Acute inflammation is characterized by neutrophilic infiltrates (1). While 
neutrophils are essential components of the inflammatory response, their potent 
secretory products can cause tissue damage and contribute to the pathogenesis of 
a variety of diseases (2). 
In inflammatory sites, the endothelium plays an active role in the recruitment 
of neutrophils and other leukocytes by expressing surface adhesion molecules that 
interact with complementary ligands on leukocytes (3). Leukocyte adhesion to the 
endothelium involves transient events between endothelial and leukocyte 
adhesion molecules that result in the extravasation of leukocytes. This process, in 
the case of neutrophils, involves three steps: initial attachment and rolling of 
neutrophils along the activated endothelium, firm adhesion of activated neutrophils 
to the endothelium, and extravasation of neutrophils into the surrounding inflamed 
tissue (4). 
The endothelial-leukocyte adhesion molecules are members of three 
families: the integrin superfamily, the immunoglobulin superfamily, and the 
selectins. Integrin and immunoglobulin superfamily members mediate the firm 
adhesion of activated neutrophils to the endothelium and their subsequent 
extravasation. The remaining family, the selectins, mediate the rolling phase of 
neutrophil recruitment. 
E-selectin, P-selectin, and L-selectin are the three known members of the 
selectin family. E- and P-selectin are expressed on the surface of activated 
endothelial cells in areas of acute inflammation, while P-selectin is also expressed 
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on activated platelets. L-selectin is constltutively expressed on the surface of a 
variety of leukocytes including neutrophils (5). 
Studies characterizing the expression and function of adhesion molecules 
have used antibodies recognizing functional epitopes. These "blocking" antibodies 
bind to the adhesion molecule and block interaction with the ligand. Adhesion 
molecule antagonists, such as blocking antibodies, can therefore be used to 
examine the relative importance of a particular adhesion pathway in the 
extravasation of leukocytes (6). In addition, and perhaps more importantly, 
adhesion molecule antagonists may represent a novel approach to the treatment of 
neutrophll-mediated inflammatory diseases. 
The adhesion molecule of interest in these studies was E-selectin, because 
novel, previously unavailable reagents have been generated to examine its role in 
murine inflammation. Understanding the role of E-selectin in mice is a critical link 
to full characterization of this molecule in other species. Potentially, adhesion 
pathways that are shown to be crucial in animal models of inflammation could be 
blocked in neutrophll-mediated diseases of humans. Studies in animal models of 
disease have already demonstrated a reduction in tissue injury by blocking a 
variety of adhesion molecules, and human trials are currently underway using an 
anti-CD18 (a member of the integrin superfamily) monoclonal antibody. 
Statement of objectives 
• Develop and characterize murine models of acute inflammation to 
examine the role of E-selectin. 
• Describe the expression of E-selectin and, secondarily, P-selectin in a 
murine model of acute inflammation. 
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• Examine the ability of selectin antagonists to block the infiltration of 
neutrophils into the site of inflammation In vivo. A second, related question 
was examined: Is there redundancy in the selectin family such that 
blocking both E- and P-selectIn results in an additive decrease in 
inflammation? 
• Characterize the phenotype of transgenic mice deficient in the gene for E-
selectin and utilize these mice to study the role of E-selectin in models of 
acute Inflammation. 
Explanation of dissertation format 
This dissertation Is in a non-traditional format arranged in parts. The style is 
based on the American Review of Respiratory Disease. Each part is meant to 
stand alone. However, the organization into parts is for the purpose of the 
dissertation. The material is not intended for publication in the format presented. 
This work, which took place in the Department of Toxicology and Pathology at 
Hoffmann-La Roche, Inc., Nutley, NJ, was part of the in vivo support for a much 
larger research effort examining the role of adhesion molecules, E-selectin in 
particular, in inflammation. Several portions of this work will be published in 
collaboration with these colleagues. A literature review precedes the first paper. 
All cited literature appears once at the end of the dissertation. 
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LITERATURE REVIEW 
Neutrophils as mediators of Inflammation 
Infiltration of neutrophils is a hallmark of acute inflammation. These 
leukocytes accumulate in areas of acute inflammation where they play a crucial 
role in defense against bacterial infections and removal of damaged or necrotic 
cells. The necessity for neutrophils in host defense is illustrated by the increased 
susceptibility to infection and decreased life expectancy of individuals lacking the 
ability to mount an appropriate acute inflammatory response (7). However, while 
neutrophils are necessary and protective, they can also cause tissue damage. 
These destructive activities likely contribute to the pathogenesis of a variety of 
disease states, including adult respiratory distress syndrome (ARDS) (8), 
rheumatoid arthritis (9), reperfusion injury (10,11), and ulcerative colitis (12). 
Phagocytosis is the process through which neutrophils attach to, engulf, and 
kill or degrade invading pathogens and/or particulate matter. Attachment requires 
recognition of the bacterium as foreign which can occur to a limited degree without 
serum (1) but is most efficient when opsonins, such as antibodies and complement 
components, coat the particle. Engulfment proceeds through the extension of 
pseudopodia around the object being phagocytized thus forming a membrane 
bound phagosome which fuses with lysosomes creating a phagolysosome. Killing 
and degradation involve a variety of mechanisms which are by convention divided 
into two systems based on location within the neutrophil: plasma membrane and 
intracellular granules (2). These two systems were once thought to operate as 
distinct entities but are now known to act synergistically in the destruction of both 
invading pathogens and adjacent host tissues (13). 
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The membrane-associated system utilizes an NADPH oxidase present in the 
neutrophil plasma membrane to produce toxic oxygen metabolites via the oxidation 
of NADPH and reduction of oxygen (14). These reactive oxygen species, including 
HgOg and the hydroxyl radical, are capable of mediating endothelial damage (15, 
16). Perhaps more importantly, hydrogen peroxide combines with a haiide in the 
presence of myeloperoxidase contained in the azurophilic granules of the 
neutrophil to form a hypohalous acid with enhanced killing and tissue destructive 
ability (1, 2). The hypohalous acid HOCI, formed from the oxidation of a chloride 
ion, Is a very potent oxidant and is produced in large quantities (17) by activated 
neutrophils, suggesting it may play an important role in neutrophil mediated-
damage. 
While the NADPH oxidase system lacks specificity and has products with 
relatively short half-lives, the enzymes contained within the neutrophil intracellular 
granules can catalyze multiple reactions and attack specific substrates. IVIore than 
20 of these enzymes have been identified, including microbicidal enzymes, neutral 
proteinases, metalloproteinases, acid hydrolases, and lactoferrin (2). Proteolytic 
enzymes, such as elastase, coliagenase, and gelatinase normally play a role In the 
degradation of the extracellular matrix as part of repair processes. Their activity is 
limited by powerful antlproteinases, such as ai-proteinase inhibitor and ocg-
macroglobulin, present in serum and extracellular fluid (18, 19). When the balance 
between the proteinases and antlproteinases is lost, the proteinases can cause 
injury of viable tissues. In vitro (20, 21, 22) and in vivo (23) studies have 
demonstrated a role for neutrophil-derived proteinases in neutrophil-mediated 
injury. Oxidants produced by the NADPH oxidant system inactivate proteinase 
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inhibitors creating a synergy which enhances the neutrophil tissue destructive 
capabilities (24, 25). 
Endothelial cell-leukocyte Interactions 
Neutrophil extravasation into sites of inflammation is dependent upon their 
adherence to the local endothelium (26). Two basic mechanisms which mediate 
this interaction have been described (27). The first mechanism is direct activation 
of the leukocytes by inflammatory mediators, such as leukotriene 64 (LTB4) (28), f-
Met-Leu-Phe (fMLP), and C5a (29). Once activated, neutrophils are able to adhere 
to unstimulated endothelial cells in vitro but only under conditions of flow with wall 
shear stress lower than would be encountered in vivo (30) suggesting that this 
mechanism may be an in vitro artifact. The second proposed mechanism involves 
cytokine activation of endothelial cells with subsequent leukocyte rolling along the 
endothelium, activation of the leukocytes, and finally stable adhesion prior to 
migration of leukocytes into the surrounding tissue (Fig. 1). This dynamic, three-
step model of leukocyte interaction with the endothelium (rolling, leukocyte 
activation, firm adhesion) was first suggested by Kishimoto (31) and shortly 
thereafter supported by Butcher (32). That leukocytes leave the stream of flowing 
blood in the center of a post-capillary venule and roll along the endothelium prior to 
extravasation has been proposed for over a century (33) and was described in 
detail in the 1970s (34, 35, 36). However, the exact mechanisms which mediate 
the interaction of leukocytes with endothelial cells has been delineated more 
clearly only in the last decade during which a vast amount of work has been done 
to define and clarify leukocyte-endothelial interactions and the involved adhesion 
molecules. There are three superfamilies of molecules with members 
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Figure 1. Illustration demonstrating the three step model of leukocyte interaction 
with endothelial cells (EC). Step 1 represents leukocyte flow through a 
vessel with no inflammatory stimulus. Step 2 shows the rolling that 
occurs when the selectins interact with their ligands on activated 
endothelial cells. Symbols for the selectins and selectin ligands are 
Interchangeable to represent the presence of L-selectin on the leukocyte 
while E- and P-selectin are expressed on endothelial cells. Step 3 
demonstrates the firm adhesion of activated leukocytes with endothelial 
cells which is followed by extravasation of the leukocytes. From: 
Adhesion: Its Role in Inflammatory Disease by Harlan. Copyright © 
1991 by W.H. Freeman and Company. Reprinted with permission (4). 
having known roles in the interaction of neutrophils with endothelial cells: 
integrins, immunoglobins, and selectins. 
Integrin superfamily 
The P2 integrins, also known as the leukocyte integrins (37, 38), are the 
most widely studied of the leukocyte-endothelial cell adhesion molecules. They 
belong to the much larger integrin superfamily whose members are heterodimeric, 
cell-surface glycoproteins composed of an a and a p subunit. The integrins have 
three subfamilies grouped by their p subunits (pi, (32, or ps) with each subfamily 
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Table 1 
The leukocyte Integrlns 
adhesion 
molecule pseudonyms 
cellular 
distribution control llgand 
CD11a/CD18 LFA-1, auPz all leukocytes constltutlvely expressed, 
avidity controlled 
ICAM-1,2,3 
CD11b/CD18 Mac-1, Mo-1, 
amP2> CR3 
granulocytes, 
monocytes, 
macrophages, 
large granular 
lymphocytes 
constltutlvely expressed, 
up-regulated from 
granules, avidity 
controlled 
ICAM1.2, iC3b. 
fibrinogen, LPS 
CD11C/CD18 pi50,95, axp2. 
CR4 
granulocytes, 
monocytes, 
macrophages 
constltutlvely expressed, 
up-regulated from 
granules, avidity 
controlled 
fibrinogen, C3d, 
C3bi 
having distinct characteristics. The leukocyte integrins have the p2 subunit, 
designated CD18, noncovalentiy bound to one of three different asubunits, 
GDI la, CD11b, or CD11c, forming what are known as LFA-1, Mo-1/Mac-1/CR3, 
and p150,95 respectively (Table 1) (39, 40, 41). 
As suggested by the name, the leukocyte integrins are found exclusively on 
leukocytes and hematopoetic progenitor cells (Fig. 2). CD11a/CD18 (LFA-1) is 
present on all leukocytes and plays an important role in adhesion and cell-
mediated cytotoxicity involving lymphocytes in particular. CD11b/CD18 (Mac-1) 
expression is limited to granulocytes, monocytes and macrophages, and large 
granular lymphocytes. It has a variety of functions, including binding to iCSb, 
through which it mediates leukocyte adherence and aggregation, chemotaxis, 
antibody-dependent cellular toxicity, and phagocytosis and intracellular killing of 
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Salectins CD11a,b,c/CD18 
VCAM-1 
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Figure 2. Model of a leukocyte and an endothelial cell demonstrating the location 
of the various adhesion molecules on each cell type. Not all molecules 
will be present on a particular type of leukocyte or a given endothelial 
cell. Modified figure reproduced, with permission, from the Annual 
Review of Immunology, Volume 11, ©1993, by Annual Reviews of 
Immunology (3). 
iC3b-opsonized microorganisms. The expression of C011c/CD18 (pi 50,95) is 
limited to granulocytes, monocytes, and macrophages, and its main function is an 
involvement in monocyte adherence and aggregation (42). 
LFA-1 and Mac-1 are the integrins responsible for binding stimulated 
neutrophils to the endothelium and are also involved in their subsequent 
transendothelial migration (43, 44, 45). Surface expression of both molecules 
increases upon activation of neutrophils by a wide variety of stimulatory factors 
including phorbol esters, fMLP, tumor necrosis factor-a (TNF), and C5a (38). 
However, increased surface expression is not correlated with the ability of the 
neutrophils to bind to the endothelium (46) suggesting the requirement for a 
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conformational change resulting in an increased avidity prior to the adhesive event 
(41, 47). For example, LFA-1 on the surface of phorbol ester-stimulated, adherent 
T lymphocytes is converted from a low affinity to a high affinity state without a 
change In surface density (48, 49). 
The autosomal, recessive congenital condition known as leukocyte 
adhesion deficiency I (LAD 1) clearly demonstrates the importance of the P2 
integrins. LAD I is a syndrome characterized by severe and recurrent infections, 
delayed wound healing, and marked peripheral blood granulocytosis which results 
from a deficiency or lack of surface expression of these integrins due to a defect in 
the CD18 component of the heterodimer (42). Numerous studies using blocking 
monoclonal antibodies (MAb) to functional epitopes on CD11/CD18 have 
confirmed the role P2 integrins play in vitro (28, 37) and in vivo (6). In addition, 
transgenic mice with a hypomorphic (partially deficient) GDI8 allele mimic the 
clinical signs seen in LAD 1 patients. They represent a useful, albeit somewhat 
diluted, model for this syndrorne and further demonstrate the role of the p2 integrins 
(50). 
Immunoglobulin superfamily 
Members of the immunoglobulin (Ig) superfamily comprise the 
complementary endothelial ligands for the leukocyte integrins. These adhesion 
molecules, like all Ig superfamily members, are characterized by Ig homology 
domains each containing a disulfide loop. To date, four Ig family members which 
are involved in leukocyte-endothelial cell interactions have been identified and 
cloned: intercellular adhesion molecule-1 (ICAM-1) (51), intercellular adhesion 
molecule-2 (ICAM-2) (52), intercellular adhesion molecule-3 (ICAM-3) (53, 54), and 
vascular ceil adhesion molecule-1 (VCAM-1) (55) (Table 2). 
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Table 2 
The immunoglobulin superfamily 
adhesion 
molecule 
structural 
characteristics 
cellular 
distribution control llgand 
bind PMNto 
endothelium? 
VCAM-1 7 Ig-like 
domains 
endothelial cells, 
macrophages, 
myoblasts, bone 
marrow 
fibroblasts 
cytokine and 
LPS induced 
expression 
VLA-4, a4Pi 
integrin 
no 
ICAM-1 
(CD54) 
5 Ig-like 
domains 
ubiquitous constitutively 
expressed at low 
level, induced by 
LPS and 
cytokines 
LFA-1, Mac-1, 
CD43; adhesion 
isCa++-
dependent 
yes 
ICAM-2 2 Ig-like 
domains 
endothelial cells, 
lymphocytes, 
monocytes 
constitutively 
expressed 
LFA-1: Ga++. 
dependent 
yes 
ICAM-3 5 Ig-like 
domains 
ail leukocytes constitutively 
expressed 
LFA-1: Ca++. 
dependent 
no 
VCAM-1 Present on cytokine- and LPS-actlvated endothelial cells (Fig. 2), 
tissue macrophages, dendritic cells, myoblasts, and bone marrow fibroblasts (55), 
VCAM-1 is the ligand for very late antigen-4 (VLA-4) (56) which is not a pg integrin 
but rather a integrin. The subfamily, also referred to as the VLA proteins, 
contains at least six members whose main function is attachment of cells to the 
extracellular matrix through recognition of the tripeptide RGD (57). The VLA 
proteins can specifically interact with collagen, fibronectin, and/or laminin (58). In 
general, VLA-4 is present on lymphocytes, monocytes, and several T- and B-cell 
leukemic lines but not on neutrophils. Human neutrophils do not bind to VCAM-1 
nor is their binding to cytokine-activated human umbilical vein endothelial cells 
(HUVE) inhibited by a blocking anti-VCAM-1 antibody (41). 
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ICAM-1 The remaining members of the Ig family involved in leukocyte 
adhesion, the intercellular adhesion molecules (ICAMs), were identified by their 
ability to bind LFA-1 (54, 59, 60, 61, 62). ICAM-1 (CD54) has five Ig-like domains 
(63), contains no RGD motifs, and bears homology to the neural cell adhesion 
molecule, NCAM (51). Its expression on many cell types including endothelial cells 
(Fig. 2), lymphocytes, macrophages, and many epithelial cells is cytokine-inducible 
(64). ICAM-1 has low, constitutive expression on endothelial cells which is 
significantly increased by interleukin-1 (IL-1), TNF, interferon-y (IFN-y) (65), and 
bacterial lipopolysaccharide (LPS) (66). The protein synthesis-dependent 
expression is increased rapidly in the first 3 hours and remains elevated for up to 
36 hours (40). Mac-1 (CD11b/CD18) is another ligand for ICAM-1 and binds in a 
manner which is more temperature sensitive and lower in avidity than the LFA-
1:ICAM-1 interaction (67). Mac-1 interacts with the third domain of ICAM-1 while 
LFA-1 interacts with the first domain (63). In addition, ICAM-1 on activated 
endothelial cells mediates adhesion of unactivated neutrophils via LFA-1, while 
adhesion in the presence of chemotactic factors, which stimulate neutrophils, is a 
Mac-1-dependent process (43). The importance of ICAM-1 in vivo is demonstrated 
by transgenic mice deficient in ICAM-1, which have decreased neutrophil migration 
into the peritoneum following intraperitoneal (IP) instillation of thioglycollate (68). 
Blocking MAb to ICAM-1 have also been demonstrated to inhibit neutrophil, 
eosinophil, and lymphocyte emigration in several in vivo models of inflammation 
(69, 70, 71, 72, 73). 
ICAM-2 ICAM-2, another member of the Ig superfamily, has two Ig-like 
domains which share homology with the two amino-terminal domains of ICAM-1 
(52). It is present on the surface of resting lymphocytes and unstimulated 
endothelial cells (Fig. 2) and is not inducible with cytokines or LPS making it the 
predominant ligand for LFA-1 on resting endothelial cells (74). LFA-1 is the only 
known ICAM-2 counter-receptor and has lower affinity for ICAM-2 than ICAM-1. 
Blocking MAb studies have demonstrated that LFA-1-dependent binding to both 
resting and activated endothelial cells could be totally accounted for by ICAM-1 
and ICAM-2 together (61 ). 
ICAM-3 While ICAM-1 and ICAM-2 play a role in neutrophil adhesion to 
endothelial cells, ICAM-3 appears to have no involvement in neutrophil localization 
in inflammatory conditions. It is a recently cloned molecule which was identified by 
monoclonal antibodies based on its high expression on all leukocytes, ability to 
bind LFA-1 (54), and its ability to inhibit lymphoblastoid cell adhesion to purified 
LFA-1 independent of ICAM-1 and ICAM-2 (62). Composed of five Ig-like domains 
and bearing 52% amino acid identity to ICAM-1, ICAM-3 is expressed only on 
leukocytes and is completely absent on endothelial cells even following stimulation 
by LPS or cytokines (53). It is the major LFA-1 ligand on resting lymphocytes (75) 
and CD1+ epidermal dendritic Langerhans cells (76). Because of its pattern of 
expression, ICAM-3 is believed to function in the initiation of the immune response. 
Selegtin family 
The remaining family of adhesion molecules involved in leukocyte-
endothelial interactions, the selectins, currently has three known members: E-
selectin, P-selectin, and L-selectin (Table 3). Originally, the members of this family 
were studied independently by numerous laboratories in different fields of study as 
activation-induced endothelial and platelet surface proteins and the lymphocyte 
homing receptor. However, the cloning and sequencing of these molecules 
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Table 3 
The selectins 
adhesion 
molecule pseudonyms 
cellular 
distribution control llgand 
L-selectin LECAM-1, LAM-
1, Leu-8, 
gpgoMEL, mLHR 
granulocytes, 
some 
lymphocytes, 
monocytes 
constitutively expressed, 
shed from surface upon 
activation, avidity 
controlled? 
sulfated 
polysaccharides, 
phoshorylated 
monosaccharides, 
sLe®, sLe* 
P-selectin GMP-140, 
CD62, PADGEM 
endothelial cells, 
platelets 
constitutively expressed, 
upregulated from 
granules by histamine, 
PAF, thrombin, others; 
upregulated expression 
by cytokines and LPS 
sulfated 
glycolipids, sLe®, 
sLeX 
E-selectin ELAM-1, 
LECAM-2 
endothelial cells upregulated expression 
by cytokines and LPS 
sLe®, sLe* 
revealed a common structural motif composed of an NHg-termlnal Ca2+. 
dependent (C-type) lectln-llke domain (~120 residues), an epidermal growth factor­
like (EGF) domain (~30 residues), between 2 and 9 complement-regulatory 
homology (CR) repeat sequences (~60 residues each), a transmembrane domain, 
and a short intracytoplasmic tail (77, 78, 79, 80). The lectin and EGF domains bear 
the important functional epitopes as has been demonstrated using chimeras with 
missing or mixed domains, peptide blocking, site specific mutagenesis, and 
blocking antibodies which bind to these domains (78, 81, 82, 83, 84, 85, 86, 87, 88, 
89). The selectins are highly glycosylated with about 30% of their mass composed 
of carbohydrates (77,80, 90). To clear confusion created by multiple names for the 
same family and its members and to indicate the 
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 ^« Signal Cleavage Site Domain 
Figure 3. Structure of L-selectin demonstrating the characteristic domain structure 
of the seiectins: amino-terminal lectin-lil<e domain, EGF-like domain, 
complement regulatory-lil<e repeats, transmembrane domain, and the 
short cytoplasmic tail. L-selectin contains 9 complement regulatory-like 
repeats while E-selectin has 6 and P-selectin has 2. The positions of the 
exon-intron boundaries relative to the domain structure demonstrates the 
relationship between the two. Similar boundaries are present in E- and 
P-selectin. Reprinted with permission from The American Society for 
Biochemistry and Molecular Biology (91). 
carbohydrate-recognition imparted by the common lectin-like domain, the term 
selectin was proposed for this family of adhesion receptors. Using this standard 
nomenclature, members of the family are designated by a capital letter prefix 
determined by the cell type on which the molecule was originally identified 
(Erendothelium, P:platelets, L:lymphocytes) (92). 
Analysis of genomic clones of the seiectins demonstrated a correlation 
between the structural domains of the proteins and the exon-intron structure of the 
genes (Fig. 3) (91, 93, 94, 95). The lectin-like and EGF-like domains of the 
seiectins have 60% amino acid (aa) identity and the CR repeats have 40% aa 
identity (96). The lectin domain, with possible involvement of the EGF-like domain, 
is crucial for the adhesive function of the seiectins (97). Chromosomal in situ 
hybridization has been used to map the three known members of the selectin 
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family to the long arm of chromosome 1 (93, 98, 99), while long range restriction 
site analysis has demonstrated tight clustering of the selectin genes in both the 
human and mouse genome (100). This cluster is located near the complement-
regulatory proteins composed of structurally homologous CR repeats (101). 
Indirect evidence, including the above, suggests exon shuffling and gene 
duplication likely played a role in the evolution of the selectin family (97). 
L-selectin The first selectin studied as an adhesion molecule, L-selectin, 
was identified using a MAb (Mel-14) generated against a murine lymphoma. This 
MAb blocks lymphocyte binding to high endothelial venules of lymph nodes in vitro 
(102) and lymphocyte homing to lymph nodes in vivo (103). Relatively recently, it 
was realized that Leu-8, described shortly before the Mel-14 antigen as a human 
lymphocyte marker (104), is actually human L-selectin (105). 
L-selectin is constitutively expressed on neutrophils, monocytes, some 
lymphocytes, and other myeloid cells (106, 107, 108, 109, 110) and is rapidly shed 
from the cell surface by proteolytic cleavage upon cellular activation (38, 111, 112) 
a process believed to play a role in regulating the activity of this molecule (113). L-
selectin has been shown to be at least partially responsible for the adhesion of 
neutrophils, lymphocytes, and monocytes to activated endothelium in areas of 
inflammation (114, 115, 116, 117, 118). Like the integrins, it is proposed that 
leukocyte activation leads to an increase in the activity of L-selectin which in this 
case is immediately prior to being shed (119). 
P-selectin P-selectin was originally identified by a MAb generated to study 
platelet activation. Stored in alpha and dense granules of platelets and Weibel-
Palade bodies of endothelial cells (120, 121, 122), P-selectin is very rapidly 
expressed through membrane fusion of the intracellular granule with the cell 
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surface upon stimulation by inflammatory mediators, such as thrombin, 
complement components, oxygen radicals, and histamine (123, 124, 125). It 
mediates leukocyte binding to activated endothelial cells or platelets (126, 127, 
128,129). Surface expression of P-selectin is normally transient (5); however, free 
radicals result in prolonged expression which suggests the presence of activated 
neutrophils and their products could contribute to prolonged surface expression (4, 
125, 130). There is also evidence suggesting P-selectin can be synthesized de 
novo in response to cytokines, such as IL-1 and TNF (131, 132,133), although this 
does not fit the original dogma which tied P-selectin to early stages of inflammation 
only (4). Within minutes after its expression on the surface of endothelial cells, P-
selectin begins to be downregulated via endocytosis with routing through the Golgi 
and recycling back to Weibel-Palade bodies (134). 
A strain of transgenic mice deficient in the P-selectin gene fully illustrate the 
importance of P-selectin in neutrophil extravasation at sites of inflammation. These 
mice have elevated peripheral neutrophil counts, virtually total absence of 
neutrophil rolling in exteriorized mesenteric venules, and delayed recruitment of 
neutrophils into the peritoneal cavity following intraperitoneal thioglycollate 
instillation (135). 
E-selectIn E-selectin, unlike P- and L-selectin, is not constitutively 
expressed but requires de novo RNA and protein synthesis (27, 136). In vitro 
exposure to the cytokines iL-1a , IL-lp, and TNF as well as bacterial LPS or 
substance P result in E-selectin expression on the surface of endothelial cells 
within 1-2 hours with maximal expression at 4-6 hours and a decline to nearly 
basal levels by 24 hours (110, 136, 137, 138). The upregulation of E-selectin 
expression occurs via massive gene transcription (139). While interferon-y does 
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not induce E-seiectin expression, it can prolong its expression in response to otiier 
cytokines (140, 141). E-selectin expression is also regulated by programmed 
disappearance both by internalization and subsequent lysosomal degradation and 
by release from the surface of the activated endothelial cells (134, 142, 143, 144, 
145). 
In vivo, like in vitro, E-selectin expression has experimentally been 
demonstrated by immunohistochemical staining and Northern blotting to begin 1-2 
hours after stimulation by LPS, TNF, or IL-1 given intradermally (ID) or 
intravascularly (IV) to primates or rodents (146,147,148). With a single injection of 
an inflammatory stimulus, this expression peaks at approximately 4-6 hours and 
returns to very low levels or is absent by 24-48 hours after the stimulus (149, 150). 
Studies in humans have demonstrated E-selectin expression in a wide variety of 
conditions including cardiac allograft rejection, atopy, ultraviolet B skin exposure, 
systemic sclerosis, graft-versus-host disease, and rheumatoid arthritis (151, 152, 
153,154,155,156). It is interesting to note the prolonged expression of E-selectin 
in chronic conditions since in vitro data had not suggested the sustained 
expression of E-selectin for the days and sometimes weeks duration which is seen 
in vivo in natural disease states. 
E-selectin mediates binding of neutrophils, eosinophils, basophils, 
monocytes, and cutaneous lymphocyte associated antigen expressing (CLA+) 
CD4+ memory T cells to activated endothelial cells (157, 158, 159, 160, 161). 
Leukocyte binding to E-selectin is not, unlike many of the other adhesion 
molecules, augmented by activation of the leukocytes (162). The interaction of 
human neutrophils with E-selectin on endothelial cells results in the activation of 
CD18 and subsequent integrin-immunoglobulin mediated binding (163, 164). 
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The endothelial cell specific expression of E-selectin and induction by 
cytokines has led to interest in the regulatory 5' flanldng region of the gene. 
Consensus binding sequences for both NF-KB and AP-1 transcription factors are 
present in this region in the human E-selectin gene, while the NF-XB-ilke sequence 
is missing from the murine gene (93, 165). The murine gene retains cytokine 
inducibility albeit at a lower level than the human homologue (165). In human 
umbilical vein endothelial cells, NF-KB-like protein activation is necessary but not 
sufficient for cytokine induction of E-selectin gene transcription (139). Two E-
selectin promoter elements and their DNA-binding factors, NF-ELAIVI1 and 2, which 
are well conserved in rabbits, mice, and humans, have been identified. These 
elements are, along with NF-KB, essential for E-selectin transcription (166). The 
NF-KB-like activation is protein kinase C (PKC)-independent: however, PKC 
agonists can, alone, stimulate expression of E-selectin (167, 168). Inhibition of E-
selectin expression has been achieved by corticosteroids and pharmacologic 
elevations of cyclic AMP (cAMP) levels (169,170). 
Soluble selectins Soluble isoforms of the selectins have been identified in 
the circulating blood of normal individuals (144, 171, 172, 173). The soluble form 
of P-selectin, sP-selectin, represents an alternately spliced variant lacking the 
transmembrane domain (174), while soluble L- and E-selectin (sL- and sE-selectin) 
are released from the surfaces of activated cells by an as yet incompletely 
understood process of proteolytic cleavage . The soluble selectins, when bound to 
a plastic surface, are capable of mediating the adhesion of target ceils (175). 
Elevated serum levels of soluble selectins are seen in a variety of disease 
states including elevated sP-selectin in thrombotic thrombocytopenic purpura and 
hemolytic uremic syndrome, elevated sE-selectin in septic shock and renal failure, 
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and elevated sL-selectin In sepsis and AIDS (144, 171, 175, 176). There Is some 
evidence that the soluble selectins may have anti-Inflammatory activity. For 
instance, sP-selectIn blocks TNF-mediated activation of the p2 integrin complex 
thus interfering with CD lib-mediated binding of PMN to the endothelium (177). 
While sE-selectIn and sL-selectIn have been shown in vitro to Inhibit leukocyte 
adhesion (173, 178); It has been suggested that soluble selectins, through their 
anti-Inflammatory activity, may serve to limit leukocyte-endothellal cell interactions. 
Members of the immunoglobulin family, such as ICAM-1 and VCAM-1 have had 
soluble forms Identltified as well (143,175). 
Selectin liçands Cloning of the selectins identified the presence of the 
common amino-termlnal domains which are homologous to the C-type lectins 
suggesting carbohydrates may be the natural ligands for the selectins. 
Involvement of carbohydrates in lymphocyte adhesion had been suggested in 
studies which predate the cloning of the selectins. Both mannose-6-phosphate 
and certain other phosphorylated monosaccharides and PPME (phosphomannin), 
a mannose-6-phosphate containing yeast core polysaccharide, blocked 
lymphocyte adhesion to lymph node high endothelial venules (179). The 
relationship between the selectins and carbohydrates was first suggested when 
lymphocyte binding to phosphomannin-coated beads was blocked by Mel-14 anti-
L-selectln antibodies (180). 
The search for carbohydrate ligands to the selectins involved various 
techniques, including neutralizing antibodies, soluble carbohydrate inhibitors, 
transfectlon by fucosyltransferases, enzymatic modification of carbohydrates, and 
direct binding of cells/receptors to purified endogenous ligands (181). There is 
however, much controversy about the exact nature of the selectin ligands. Much of 
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the confusion has arisen from the assumption that dogma regarding protein-protein 
interaction is applicable in the context of iectin-carbohydrate interactions. Applying 
knowledge obtained from previous studies of plant and animal lectins can be 
helpful when interpreting results from selectin-carbohydrate studies (182). A major 
difference between protein-carbohydrate and protein-protein interactions is the 
lower affinity and restriction of the protein-carbohydrate bonds. Experimental 
conditions such as temperature, time, and shear force can significantly affect Iectin-
carbohydrate interactions and lead to erroneous conclusions. In addition, 
apparently unrelated oligosaccharides can mimic one another in free solution 
thereby inhibiting the same ligands. 
Each of the selectins has been demonstrated to bind to various natural and 
synthetic sugars which can be categorized into three basic types; sialylated Lewis 
X (sLe*) and related structures (sLe^), phosphorylated mono- and polysaccharides 
(mannose-6-phosphate, PPME), and sulfated polysaccharides (fucoidan, heparin) 
(5). In 1990 a pentasaccharide termed LNF-III and containing the Lewis x 
determinant (Le*: Gaipi-4(Fuca1-3)GlcNAc) was shown to block P-selectin-
dependent platelet resetting (183). The sialylated form of Le* (sLe*: Neu5Aca2-
3Galp1-4(Fuca1-3)GlcNaAc) (Fig. 4) was found to be a ligand for E-seiectin by 
several groups of investigators less than 2 years after the cloning of the gene (81, 
184, 185, 186, 187). The demonstration that this sialylated, fucosylated 
lactosaminoglycan is recognized by P-selectin and L-selectin followed (188, 189, 
190, 191). The sialic acid and fucose residues are required and must be in specific 
linkages in order to serve as ligands for the selectins (181, 192, 193, 194). 
Molecules containing a related molecule, sialyl Lewis a (sLe^: (Neu5Aca2-
3Gaipi-3(Fuca1-4)GlcNAc) (Fig. 4), interact with murine L-selectin and human E-
22 
and P-selectin (190, 194, 195, 196). Fucosylated lactosamines including sLe* are 
found on the surfaces of neutrophils, monocytes, some lymphocytes and a variety 
of cancer cells (195, 197, 198, 199, 200); while sLe^ is not usually present on 
peripheral leukocytes but is prevalent on certain cancer cells suggesting a role for 
sLea in cancer metastasis (81, 201, 202). 
^ NeuSAea2>3Gaipi-4GlcNAe — Aw 
I , , N(u5Aca3>3Gaipi<3 GlcNAc -
MCOm J I 
Fucal«4 
Figure 4. Structure of the sLe^ and sLe^ selectin ligands. These oligosaccharides 
contain a terminal sialic acid (Neu5Ac) linked a2-3 to galactose (Gal) 
which is linked to N-acetylglucosamine (GlcNAc) with a fucose attached. 
The galactose and fucose linkage to the GlcNAc differs between the two 
sugars. Reproduced from the Journal of Clinical Investigation, 1993, vol. 
91, pp. 379-387 by copyright permission of the American Society for 
Clinical Investigation (5). 
As discussed above, there is controversy surrounding identification of the 
selectin ligands. The subject is reviewed thoroughly in Bevilaqua and Nelson, 
1993 and Bevilaqua, 1993 (3,5). Binding of selectins to their target cells is a 
calcium-dependent, saturable, high affinity event (97). There is some consensus 
about the carbohydrate ligands for the selectins which can be summarized as 
follows: P-selectin binds certain sulfated glycolipids, such as sulfatide, in addition 
to sLe* and sLe^; while E-selectin binds only to sLeX, sLe^, and related structures. 
L-selectin can bind sulfated polysaccharides, phoshorylated monosaccharides. 
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and sLeX and sLe^ although it appears to have a lower affinity than E-selectin for 
these two sugars (5). Identification of the simplest monosaccharide or 
oligosaccharide ligand is useful but only tells a partial story, because these simple 
units are part of a larger more complex molecule with combinations of 
oligosaccharides from the same or adjacent macromolecules involved in lectin 
binding. Two children with a defect in fucose metabolism resulting in an inability to 
fucosylate carbohydrates have been identified. The neutrophils from these patients 
lack sLex and are unable to adhere to activated endothelial cells thus 
demonstrating the importance of sLe* in neutrophil adhesion to endothelial cells 
(203). 
Proteins have also been examined for potential involvement in selectin-
mediated adhesion. E-, P-, and L-selectin bind with high affinity to a small number 
of specific cell surface proteins. For example, immunoprecipitation of murine lymph 
nodes with a MAb (MECA-79) against the peripheral lymph node addressin 
identified several glycoprotein species between 50 and 200 kDa (204). Two of 
these molecules appear to correspond to the 50 and 90 kDa sulfated, sialylated, 
and fucosylated glycoproteins which were affinity purified from murine lymph nodes 
using an L-selectin-lg chimera (205). A cDNA encoding the 50 kDa glycoprotein 
was isolated and found to encode a novel mucin-like cell adhesion molecule with 
clusters of carbohydrates (206). This molecule was later named GlyCAM-1(97). P-
selectin was used to affinity purify a 120 kDa glycoprotein from myeloid cells (207) 
that has been proposed to be involved in the presention of carbohydrates to P-
selectin. Soluble E-selectin identified a 150 kDa glycoprotein as the only species 
that could be affinity isolated from mouse myeloid cells (208). Interestingly, 
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protease treated HL60 cells (a myeloid leukemia line) can still bind E-selectin but 
can no longer bind P-selectin (209). 
Selecting and leukocyte rolling Selecting mediate the rolling phase of 
neutrophil extravasation (Fig. 1) (31, 33, 115, 135, 210, 211) via rapid binding and 
low detachment rate between the selectins and their carbohydrate ligands located 
on the ends of flexible protein counter-receptors on neutrophils (212). Bond length 
and flexibility play a crucial role in the ability of leukocytes to roll at a variety of 
shear rates (213). Rolling is mediated by adhesive events rather than 
hemodynamic factors (214) and Is the first recognizable interaction between 
neutrophils and activated endothelium. It is reversible as in cases of mild 
inflammation in which leukocytes are released and return to the flowing 
bloodstream or can result in stable adhesion and subsequent extravasation (34). 
Examination of the venules in intact mouse ears suggests neutrophil rolling may be 
a normal physiologic process in unlnflamed tissues (215). 
The rolling phenomenon can be studied in vitro using parallel-plate flow 
chambers with shear stresses equal to those found in post-capillary venules (1-4 
dynes/cm^) (216, 217) or in vivo via intravital microscopy (115, 218, 219). 
Exteriorization of tissues in preparation for intravital microscopy alone has been 
shown to induce rolling (219). As early as 1967, leukocyte rolling was reported to 
depend upon divalent cations as evidenced by absence of rolling upon 
superfusion with EDTA (220) and was later shown to be inhibited by dextran sulfate 
(221). 
Studies provide evidence for selectin mediation of the rolling process. In 
vitro, MAb to L-selectin blocks neutrophil adhesion to activated, cultured 
endothelial cells under conditions of flow, a state in which MAb to GDIS had no 
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effect (211, 222). Intravital microscopy has illustrated L-selectin- mediated rolling 
of rabbit, human, and rat neutrophils in mesenteric venules (115, 210, 218). 
Flowing neutrophils can roll on surfaces coated with purified P-selectin, histamine-
stimulated endothelial cells, or immobilized, activated platelets providing in vitro 
evidence for P-selectin-mediated neutrophil rolling (33, 223, 224) In addition, 
neutrophils in transgenic knockout mice deficient in the gene for P-selectin do not 
roll in mesenteric venules. In the case of E-selectin, under conditions of flow, 
neutrophils roll along immobilized, purified E-selectin and E-selectin transfected L-
cell monolayers (225). This rolling is completely inhibited by anti-E-selectin 
antibodies and is inhibited more than 65% by anti-L-selectin antibodies suggesting 
a shared adherence pathway for these two selectins (226). 
L-selectin may be particularly important in the roiling phenomenon. Picker 
et al. demonstrated that L-selectin-mediated neutrophil adhesion in vitro is 
accounted for, in part, by neutrophil L-selectin presentation of oligosaccharides, 
including sLex to E-selectin and P-selectin expressed on vascular endothelial cells 
(227). This was supported by work showing that anti-E-selectin and anti-L-selectin 
antibodies do not have additive effects although each alone is additive with anti-
ICAM-1 antibodies (116). L-selectin is constitutiveiy expressed at high levels and 
concentrated on the neutrophil surface microvilli (227) making it uniquely suited for 
a central role in the rolling of unactivated neutrophils along the surface of activated 
endothelial cells. 
Rolling neutrophils are slowed enough to allow them time to become 
activated by chemical mediators in the local environment (38), or on the surface of 
the endothelial cells. For example, adhesion to the selectins (163) or interaction 
with platelet activating factor (PAF) (228) result in neutrophil activation. Upon 
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activation, neutropliiis undergo dramatic, rapid clianges including shedding of L-
selectin (38) and an increase In P2 integrin avidity for their ligands (44, 46). Once 
activated, the leukocytes are able to interact with the endothelium in a stable 
manner. 
Stable adhesion of neutrophils is required prior to extravasation, and unlike 
rolling, is mediated by the leukocyte integrins. Work by Arfors et. ai. demonstrated 
that, In vivo, anti-CD18 monoclonal antibodies prevent the firm adhesion and 
extravasation of neutrophils but not their rolling along post-capillary venular 
endothelium (231). In vitro experiments have elegantly modeled the requirement 
for each of these three steps in the interaction of neutrophils with endothelial cells 
prior to extravasation (33, 211). These models involved neutrophil interactions with 
either purified adhesion molecules or activated endothelial cells and demonstrated 
the importance of selectins in rolling followed by activation of the neutrophils and 
subsequent stable adhesion mediated by the integrin-immunoglobulin 
counterreceptors. All three steps were shown to be essential. 
Blocking selectin-mediated inflammation Animal models of inflammation 
have been utilized to demonstrate the importance of the selectins in mediating 
inflammation In vivo. A variety of antagonists including, MAb, selectin chimeras, 
and carbohydrates have been shown to reduce neutrophil influx and inflammation 
in these models which have examined several different tissues and inflammatory 
stimuli. Table 4 summarizes these studies. 
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Table 4 
In vivo models in which antagonists have blocked selectins 
animal model antagonist reference 
Decrease reperfusion injury in 
the ear (rabbits) 
Inhibit neutrophil influx and 
injury in cobra venom factor 
-induced pulmonary injury (rats) 
Protect myocardium and 
endothelium in cardiac ischemia 
and reperfusion injury (cats) 
Inhibit neutrophil influx into 
peritoneum after IP 
thioglycollate (mice) 
Prevent neutrophil influx into 
inflamed skin (mouse) 
Inhibit neutrophil influx and 
injury in IgG immune complex-
induced pulmonary injury (rats) 
Reduce antigen-induced 
pulmonary neutrophil influx and 
late-phase airway obstruction 
(monkeys) 
MAb against P-selectin 
MAb against P-selectin 
L- and P-selectin-IgG chimeras 
oligosaccharides (sLe  ^and its 
anatogs) 
MAb against P-selectin 
MAb against L-selectin 
L-selectin-IgG chimera 
heparin oligosaccharides 
MAb against L-selectin 
MAb against E-selectin 
L- and E-selectin chimeras 
tetra- and pentasaccharide 
derivatives of sLe* 
MAb against E-selectin 
Winn et al. (232) 
Mulligan et al. (233) 
Mulligan et al. (234) 
Mulligan et al. (235) 
Weyrichetal. (169) 
Jutilaetal. (236) 
Watson et al. (114) 
Nelson et al. (237) 
Lewinsohn et al. (109) 
Mulligan et al. (238) 
Mulligan et al. (235) 
Mulligan et al. (239) 
Gundeletal. (240) 
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PART 1 
DEVELOPMENT AND CHARACTERIZATION OF 
MURINE MODELS OF ACUTE INFLAMMATION 
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ABSTRACT 
Two murine models of acute inflammation were developed to evaluate the 
role of the endothelial adhesion molecule E-selectin in the recruitment of 
neutrophils to areas of inflammation in the mouse. The first model, intraperitoneal 
(IP) injection of thioglycollate broth, was used to study the infiltration of neutrophils 
into the peritoneal cavity of mice (n=2 mice/dose/time point for thioglycollate treated 
mice and 1 mouse/time point for saline treated mice). Compared to IP injection of 
1.0 mL saline, significantly greater numbers of neutrophils were present in the 
peritoneal lavage fluid of mice injected with 0.5 and 1.0 mL of thioglycollate after 2 
and 4 hours. The second model, a novel model of intranasal instillation of 50 p.g 
bacterial lipopolysaccharide (LPS) in 50 ^L sterile saline, was examined using a 
time course study of histologic changes in the lungs and neutrophilic infiltration into 
the bronchoalveolar lavage (BAL) fluid in 6 mice/time point. To demonstrate that 
intranasally instilled fluid reached the lungs, gross distribution of inhaled saline 
was also evaluated. Progressively increasing numbers of neutrophils were seen in 
the BAL fluid from 1 through 6 hours after stimulation, followed by a slight decrease 
in neutrophil numbers by 24 hours. Histologic changes included mild edema and 
inflammatory cell infiltrates beginning multifocally around airways and extendeding 
into surrounding alveoli. Patchy, multifocal distribution of the inhaled saline was 
demonstrated by the addition of blue dye to the saline. It was concluded that both 
models would be potentially useful for studies examining the involvement of E-
selectin in neutrophil recruitment into sites of acute inflammation in the mouse. 
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INTRODUCTION 
While a significant number of in vivo studies have examined and more 
clearly defined the role of immunoglobulin and integrin superfamily members in 
leukocyte adherence to endothelium and emigration into sites of inflammation, very 
few studies have looked at the role selectins, particularly E- and P-selectin, play in 
vivo (6). Animal models used to evaluate the importance of adhesion molecules in 
acute inflammation must have quantifiable markers of inflammation such as a 
neutrophilic infiltrate or edema. When antagonists to various adhesion molecules 
are given prior to an inflammatory stimulus, it is necessary to measure a decrease 
in the inflammation in order to substantiate the importance of the molecule. 
Monoclonal antibodies are the most commonly used adhesion molecule 
antagonists and are effective inhibitors of inflammation in a wide variety of 
inflammatory conditions and tissues. Interestingly, the vasculature of different 
tissues appears to have distinct adherence mechanisms. Doerschuk et al. (1990) 
showed that CD-18-dependent neutrophil migration into the abdominal wall 
differed from that induced in the lungs. In the lungs, inflammation induced by one 
stimulus was blocked by anti-CD18 monoclonal antibodies but inflammation 
induced by another stimulus was not. Therefore, in addition to being tissue-
specific, adhesion molecules are also stimulus-specific (241). This stimulus 
specificity was further illustrated by Mulligan et al. (1991 and 1992) in rat lung 
models (238, 233). 
Because of apparent organ specificity in the role of adhesion molecules in 
acute inflammation, study of two different tissue beds was considered crucial in the 
design of experiments to examine the role of E-selectin. The lung and peritoneal 
cavity were selected because they represent sites where collection and 
31 
quantification of inflammatory infiltrates is possible via lavage. The mouse was 
chosen as the study animal, because novel reagents were available for specific 
murine adhesion molecules. 
A well characterized murine model of acute inflammation, the intraperitoneal 
(IP) injection of 0.5 to 1.0 mL of thioglycollate broth, induces a rapid and 
predictable influx of neutrophils into the peritoneal cavity (242). L-selectin has 
been demonstrated to play a role in the influx of neutrophils in this model with the 
use of anti-L-selectin MAb or an L-selectin-IgG chimera as the antagonist (236, 
114). In addition, P-selectin has been shown to be important in neutrophil 
migration into the peritoneal cavity following IP injection of thioglycollate in 
transgenic mice deficient in the gene for P-selectin (135). The P-selectin knock-out 
mice, when compared to genotypically normal mice, had lower numbers of 
neutrophils in peritoneal lavage fluid at several early time points. 
Inhalation of lipopolysaccharide (LPS) into the lungs has been described as 
a model of acute inflammation in several species. LPS, a proinflammatory 
component of bacterial cell walls, causes a measurable increase in neutrophils 
recovered by bronchoalveolar lavage (BAL) of a variety of animals, including 
guinea pigs and sheep, when it is inhaled following aerosolization (243, 244). In 
general, neutrophil numbers in the BAL peak at around 6-12 hours and return to 
baseline levels by 48 hours, while monocytic and lymphocytic infiltrates peak at 24 
and 48 hours, respectively, following inhalation of LPS by these species (245, 
246). Intratracheal and intrabronchial instillation of LPS provide additional routes 
that have been used in experimental models to deliver LPS to the air spaces of the 
lungs. These routes recapitulate the inflammatory infiltrates seen with aerosolized 
LPS (241, 245). However, administration of inflammatory mediators by the 
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intratracheal and intrabronchiai routes is technically challenging in mice due to the 
small size of the airways. Another method of LPS delivery is intranasal (IN) 
instillation of LPS. Although this route is not commonly used in inflammation 
research, it is utilized by investigators In the fields of immunology and virology 
(247, 248). Pilot studies were conducted to compare the effects of nebulized LPS 
to intranasal instillation of LPS on lung histology and the cellular composition of the 
BAL. These studies demonstrated that intranasal administration of LPS induced a 
more severe and reliable inflammatory state making it the preferred delivery system 
for the studies that followed (249). 
For these reasons, chemical peritonitis induced by intraperitoneal instillation 
of thioglycollate and pneumonitis induced by intranasal instillation of LPS were 
evaluated as models for subsequent studies of E-selectin in acute inflammation. 
The purpose of the following studies was to characterize these models. The 
primary goal of the thioglycollate study was to determine whether a reproducible 
model of peritonitis, with a significant influx of neutrophils, could be induced (as 
reported in the literature). The goals of the IN LPS study were to characterize 
neutrophil influx into the BAL, histopathologic changes, and gross distribution of an 
inhaled aqueous solution. 
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MATERIALS AND METHODS 
Thioglycollate-induced peritoneal Inflammation 
Mice 
The mice were 7 weel< old, VAF®, males of the Charles River Crl:CD-1 
(ICR)BR strain purchased from Charles River Breeding Laboratories (Raleigh, NC). 
The mice were group housed in suspended stainless steel cages over non-contact 
bedding. The murine pathogen-free environment was maintained with a 12 hour 
light/dark cycle at 72 ± 4° F and 50 ± 20% humidity. Purina Certified Rodent Chow 
5002 (Purina Mills Inc., Richmond, IN) and reverse osmosis water were provided 
ad libidum. The animals were conditioned for at least one week prior to treatment. 
Thioalvcollate administration and peritoneal lavage 
Two mice were evaluated in each thioglycoilate treatment group and at each 
time point, while the saline treatment groups had one animal per time point. Mice 
were injected IP with 0.5 or 1.0 mL of thioglycoilate broth (Sigma Chemical Co., St. 
Louis, MO) or 1.0 mL of sterile saline (Abbott Laboratories, North Chicago, IL). At 2 
and 4 hours after the IP injectipns, mice were sacrificed by CO2 inhalation. After 
removing the skin overlying the peritoneum, 10 mL of Dulbecco's phosphate 
buffered saline (PBS) (Gibco Laboratories, Grand Island, NY) containing 10 U/mL 
of heparin was injected into the peritoneal cavity. The peritoneal wall was gently 
massaged prior to withdrawal of the lavage fluid through a 22 gauge needle. 
Yields of lavage fluid were between 7-8 mUanimal. Lavage fluid was kept on ice in 
polypropylene tubes until evaluated (<30 minutes). The total number of cells in the 
lavage fluid was manually counted with a Neubauer hemacytometer. 
Cytocentrifuged cell preparations were made by centrifuging 100 ^iL of peritoneal 
lavage fluid at 800 rpm for 5 minutes on a Cytospin 2™ (Shandon Scientific Ltd., 
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Runcorn, UK) then staining the cells with a modified Wright's stain on a Hematek™ 
autostainer (Miles Laboratories, Inc., Elkhart, IN). Two slides were made for each 
animal, and differential counts were done by counting 100 leukocytes/slide using a 
light microscope at 630x oil immersion. 
Statistics 
Data were analyzed using a two-way ANOVA with a factorial design using 
dose, time and dose/time interaction as factors. Independent variables found to be 
significant at p<0.05 were then analyzed by a Student's t-test to determine if there 
was an effect due to that variable. Statistical significance was assigned when 
p<0.05. 
Intranasal LPS-induced pulmonary inflammation 
Mice 
The mice used for this study were 9 week old, male, Charles River VAF® 
Crl:CD-1 (ICR)BR mice purchased from Charles River Breeding Laboratories 
(Raleigh, NC). The animals were housed and treated as described above. 
LPS administration 
Mice were anesthetized in a desiccation chamber containing 
methoxyflurane (Metofane®, Pitman-Moore, Mundelein, IN). Once in a deep plane 
of anesthesia, mice were removed from the chamber and given an intranasal 
instillation of 50 nL of sterile saline containing 50 p,g (1.0 mg/mL) LPS (from 
Escherichia coii Serotype 055:85, Sigma Chemical Co., St Louis, MO) by placing 
the saline on the external nares of the anesthetized mouse until inhalation was 
observed. 
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Bronchoalveolar lavage 
At 1, 2, 4, 6 and 24 hours after IN instillation of LPS, 6 mice/time point were 
sacrificed via a lethal injection (0.2 mL IP) of Euthanasia 5 Solution® (Henry 
Schein Inc., Port Washington, NY). Once moribund following the lethal injection, 
they were exsanguinated by aortic transection. Bronchoalveolar lavages were 
performed by inserting an 18.5 gauge nylon catheter into a small tracheostomy 
opening of the exposed trachea. The trachea was secured to the catheter using 5-0 
sill( suture material. Lungs were lavaged in situ with a total of 4 mL of cold PBS 
containing 10 U/mL of heparin instilled in 5 repeated lavages of 0.8 mL each. BAL 
fluid was put into polyethylene tubes and kept on ice until evaluation (<30 minutes). 
Total leukocyte count in the BAL fluid was quantified with a Neubauer 
hemacytometer. Cytocentrifuged cell preparations were made by centrifuging 100 
^L of BAL fluid at 800 rpm for 5 minutes on a Cytospin 2™ followed by staining the 
ceils with a modified Wright's stain on a Hematek™ autostainer. Two slides were 
made for each animal, and differential counts were done by counting 100 
leukocytes/slide using a light microscope at 630x oil immersion. 
Histologic evaluation 
Following euthanasia and exsanguination as described above, 1.0 mL of 
10% neutral buffered formalin was instilled into the trachea of two mice/time point, 
and the trachea was ligated with 5-0 silk suture material. The inflated lungs were 
immersion fixed in 10% neutral buffered formalin. After fixation, each lobe was 
dissected free and trimmed in a standard manner, embedded in paraffin, sectioned, 
and stained with hematoxylin and eosin (H&E) for routine histologic examination. 
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Analysis of gross distribution of inhaled droplets 
Fifty microliters of saline containing monastral blue (4% by volume) (Sigma) 
was instilled intranasally into 5 mice as described above. Four hours later, the 
animals were sacrificed via a lethal injection (0.2 mL IP) of Euthanasia 5 Solution®. 
The gross distribution of the blue dye was visually evaluated and photographed. 
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RESULTS 
Thioglycollate-induced peritoneal inflammation 
Neutrophil migration into the peritoneal cavity 
Intraperitoneal injection of 0.5 or 1.0 mL of thioglycollate resulted in a 
significant acute inflammatory response in the peritoneal cavity of mice when 
compared to the saline treated animals, as measured by the total number of 
neutrophils (PMN)/mL in the peritoneal lavage fluid (Table 1). In this experiment, 
there was no effect of time or dose of thioglycollate. 
Table 1 
Neutrophil migration into the peritoneal cavity following IP thioglycollate 
an/ma/# IP treatment 
sacrifice time after 
dosing 
PMNx 10^/mLof 
peritoneal lavagate 
1 0.5 mL thioglycollate 34.52 
2 0.5 mL thioglycollate 30.64 
3 1.0 mL thioglycollate 2hr 25.73 
4 1.0 mL thioglycollate 35.41 
5 1.0 mL saline 0.37 
6 0.5 mL thioglycollate 48.64 
7 0.5 mL thioglycollate 11.12 
8 1.0 mL thioglycollate 4hr 30.16 
9 1.0 mL thioglycollate 57.15 
10 1.0 mL saline 0.26 
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Intranasal LPS-induced pulmonary Inflammation 
Neutrophil influx into the airways and air spaces of the lungs 
Intranasal instillation of 50 of 1.0 mg/mL LPS/saline into the lungs of mice 
was evaluated at 1, 2, 4, 6, and 24 hrs. The IN LPS resulted in significant 
increases in the number of neutrophils over the course of the experiment. The 
number of neutrophils recovered by BAL increased over time until 6 hours but 
declined by 24 hours (Fig. 1). In agreement with published reports of normal mice, 
essentially no neutrophils were recovered in BAL fluid of control animals receiving 
no intranasal instillation (250). The intranasal instillation of 25 |xL sterile saline did 
not result in an increase in neutrophil numbers in the BAL fluid relative to normal 
control levels (numerical data not shown) (Fig. 2). 
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Figure 1. Neutrophil numbers in the BAL fluid of mice given IN LPS 
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Figure 2. Cytospin preparations of the bronchoalveolar lavage fluid from A. a mouse 
given 50 |nL IN saline 4 hours earlier and B a mouse given an IN instilla­
tion of 50 |aL of 1.0 mg/mL LPS 4 hours earlier. Notice the increased cel-
lularity, neutrophils in particular, in the LPS-treated animal. (200X) 
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HistQpathQiogy 
Animals sacrificed at 1 and 2 hours (n=2 animals/time point) had similar 
histopathologic lesions in the lungs. There were mild infiltrates of neutrophils into 
and around many airways (especially medium-sized bronchioles) and around 
vessels associated with airways. Mild edema and margination of neutrophils along 
the endothelium were also present in these regions. From 4 through 24 hours, the 
lungs became progressively more infiltrated with leukocytes, predominately 
neutrophils, and the edema became slightly more pronounced. By 24 hours, the 
infiltrates around and within airways had progressed multifocally from mild to 
moderate and extended into the surrounding alveoli (Fig. 3). 
Qross distribution of inhaled droplets 
The monastral blue dye was visually evident on the pleural surface and 
scattered throughout the parenchyma on cut surface of the lungs in all mice studied 
(Fig. 4). The distribution varied somewhat from mouse to mouse, but approximately 
40-60% of the lungs were stained blue. The size of the individual areas varied 
from pinpoint to large (several mM) with irregular patches involving approximately 
70% of the left lobe in one mouse. In all mice, blue dye was present in all lung 
lobes, although the extent of involvement of the separate lobes varied between 
mice. Overall, the left lobe appeared to be slightly more involved in these mice. 
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Figure 3. Histopathologic changes in the lungs of mice given 25 pL of 2.0 mg/m 
LPS. 1 hr later; A. Neutrophils are seen in alveolar walls immediately sur­
rounding the ainway.(IOOX) 4 hr later: B. and C. There is mild edema and 
inflammation around the airways. B.(50X), C.(IOOX) 6 hr later: D.The 
neutrophils are present in small numbers in alveoli distant from the air­
ways.(50X) E. Neutrophil margination along the wall of a small 
venule.(200x) 24 hr later: F. The inflammation in the alveoli is moderate 
in severity.(50X) Hematoxylin and eosin. 
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Figure 4. Lungs from mice which inhaled 50 fiL of sterile saline containing 4% 
monastral blue dye to visualize the distribution of saline delivered by 
intranasal instillation. Bar=1 cm. 
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DISCUSSION 
In these studies, both the IP thioglycollate and IN LPS models had a rapid 
influx of neutrophils into the lavage fluid. The number of neutrophils recovered in 
the lavage fluid from the lungs and peritoneal cavity is reliable (see part 3 of this 
dissertation) and, in the case of the thioglycollate model, consistent with previous 
reports (114). 
The intranasal instillation of LPS resulted in an influx of neutrophils into the 
air spaces beginning by 1 hour and increasing through the first 6 hours after 
treatment. By 24 hours, the number of PMN/mL in the BAL fluid had begun to 
decrease. Time points between 6 and 24 hours were not examined, because the 
focus of these studies was the neutrophilic influx occurring in the first 6 hours of 
inflammation. Histologic examination demonstrated an influx of inflammatory ceils 
around airways early in the inflammatory response with extension into alveoli by 6 
hours. Twenty-four hours post-treatment, the inflammatory cell infiltrate in the 
alveoli had progressed from mild to moderate. Distribution of the monastral blue 
dye clearly showed that intranasal instillation of an aqueous solution is an effective 
method for delivery of inflammatory mediators to the lungs. 
The paradox between the slight decrease in neutrophil numbers in the BAL 
and increasing inflammation seen histologically has several potential explanations. 
A portion of the difference can be accounted for by an increase in mononuclear 
cells relative to neutrophils in the 24 hour post-treatment group. In addition, 
neutrophils in the alveoli may not be accessible to BAL fluid or may have increased 
adhesive properties which prevent them from being flushed from the lungs (250). 
Several problems arose during the development of the IN model. The most 
significant problem was the inability to determine whether the delivery of the LPS 
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had been successful when saline alone was used. To alleviate this problem, 
monastral blue dye was added to the saline for intranasal instillation. The grossly 
visualized dye in the lungs was a simple indicator of a successful inhalation 
exposure. 
The magnitude of neutrophilic influx into the peritoneal cavity of the mice 
receiving IP thioglycollate was similar to that reported in the literature. As reported 
by Watson et al., mice treated 4 hours earlier with 1.0 mL of thioglycollate had 
approximately 250 x 10^ PMN in the peritoneal lavage fluid while mice in this study 
had 300 X 10^ (114). Although a greater increase in neutrophil numbers in the 
peritoneal lavage fluid of mice in the 4 hour group relative to the 2 hour group was 
expected, the number of animals studied was small. (A larger sample population 
would likely have given the expected results.) Since the purpose of these 
experiments was to determine whether significant inflammation could be induced, 
the sacrifice of animals to duplicate reports in the literature was considered 
unnecessary. 
In conclusion, intranasal instillation of LPS and intraperitoneal injection of 
thioglycollate were determined to be useful models in which to study the in vivo 
role of E-selectin in acute murine inflammation. 
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PART 2 
EXPRESSION OF E- AND P-SELECTIN 
IN MICE GIVEN INTRANASAL LIPOPOLYSACCHARIDE 
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ABSTRACT 
E-selectin and P-selectin are Inducible endothelial cell adhesion molecules 
belonging to the seiectin family. They are expressed on the surface of activated 
endothelial ceils in areas of acute inflammation where they play a role in the 
recruitment of leukocytes. In this study, immunohistochemicai staining with 
monoclonal rat anti-mouse E- and P-seiectin antibodies was used to characterize 
the expression profile of these molecules in the lungs of mice following intranasal 
(IN) instillation of bacterial lipopolysaccharide (LPS). Tissue sections from mice 
sacrificed at 0 (untreated), 1,2,4, 6, and 24 hours post-treatment were evaluated 
(n=2 mice/time point for 0, 1,2, 6, and 24 hours, n=8 for 4 hours). No E-seiectin 
staining was seen in the untreated or 1 hour post-treatment groups. Staining was 
visible in endothelial cells of a small number of arterioles, small veins, and venules 
in the 2 hour group; staining peaked at 4-6 hours. The positively stained blood 
vessels tended to be located near bronchioles. Staining in the 24 hour post-
treatment group had decreased to near baseline levels. A small number of vessels 
were involved, even in the peak staining period (4 and 6 hours). In comparison, P-
selectin staining was seen at all time points between 0 and 24 hours. Basal 
expression was present in a few capillaries, small veins, and venules in the 
untreated group. The number of vessels staining for P-selectin increased in 
subsequent groups through 6 hours and extended to include larger veins, 
arterioles, and small arteries. At 24 hours post-treatment, the staining had 
decreased to a level similar to that seen in the control group. In general, the 
staining with P-seiectin antibodies involved 3-5 times more vessels than staining 
seen with E-selectin antibodies. These data indicate that E- and P-selectin 
expression was upregulated in the lungs of mice given IN LPS. At the time points 
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evaluated, expression of both adhesion molecules peaked at 4-6 hours and 
involved a small percentage of vessels. 
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INTRODUCTION 
In vitro expression of the endothelial adhesion molecule E-selectin has been 
well characterized on cultured endothelial cells stimulated by the cytokines 
interleukin-1 (IL-1) and tumor necrosis factor-a (TNF) or bacterial 
lipopolysaccharide (LPS) (77, 136). The expression peaks at 4-6 hours post-
stimulation with a gradual decline to baseline levels 24-48 hours after stimulation. 
By comparison, a related adhesion molecule, P-selectin, is very rapidly expressed 
on the endothelium. Within minutes, P-selectin appears on the surface of cultured 
endothelial cells following activation by a variety of mediators, including thrombin, 
histamine, HgOg, and terminal complement components (122, 121, 125, 130, 252). 
Expression occurs through the redistribution of P-selectin from the membranes of 
intracellular storage granules to the surface of the endothelial cell. Although the 
expression has been thought to be short-lived (3, 5), recent in vitro and in vivo 
studies have demonstrated a prolongation of P-selectin surface expression that, 
like E-selectin expression, is cytokine-induced with de novo synthesis of new 
mRNA and protein and is several hours in duration (131, 132, 133). The 
expression of P-selectin, as measured by Northern blotting, peaks at 4 hours in 
murine endothelioma cells treated with TNF (253) and in mice given intraperitoneal 
(IP) LPS (133). 
The in vivo expression of E-selectin has been described in several animal 
models, the majority of which are primate models, because (when used for 
immunohistochemical staining) the available anti-human E-selectin antibodies 
recognize E-selectin in primates but not in other species. In one study, septic 
shock was induced in baboons with live Escherichia coli, and the animals were 
sacrificed 6 hours later. E-selectin expression was detected 
49 
immunohistochemically in capillaries, venules, small veins, arterioles, and arteries 
in a wide variety of tissues (254). Another study in baboons examined the time 
course of E-selectin expression by injecting LPS into the skin and by examining 
skin biopsies with immunohistochemical staining. In these baboons, E-selectin 
expression on the endothelium of dermal venules was clearly evident by 2 hours 
after the injection of LPS and decreased thereafter to virtual absence by 9 hours 
post-treatment (150). In a similar study, E-selectin expression was compared in an 
intradermal LPS injection model and in a cutaneous delayed-type hypersensitivity 
(DTH) model in rhesus monkeys. In this study, E-selectin expression began 0.5 
hours after the LPS injection and peaked between 4-8 hours post-treatment but 
remained slightly elevated for up to 72 hours. In the DTH model, E-selectin 
expression was seen one day post-stimulation and extended through the 11 day 
study period (255). 
In mice, IP LPS has been shown to cause immunohistochemically 
detectable expression of E-selectin in the medium and small veins of the lung, 
heart, and kidney (149) in a study which used rabbit polyclonal antibodies 
generated against human soluble E-selectin rather than anti-murine-E-selectin 
antibodies. No other reports of in vivo studies examining the expression of E-
selectin in mice have been published to date. Novel monoclonal antibodies 
(MAbs), specific for murine E-selectin (256), were produced at Hoffmann-La Roche 
and utilized for the following experiment, the goal of which was to evaluate the 
expression of E-selectin over a 24 hour time course in the lungs of mice treated 
with intranasal (IN) LPS. A second objective of the study was to characterize P-
selectin expression in the model by immunohistochemistry as a prelude to 
exploring functional activity. 
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MATERIALS AND METHODS 
Mice 
The mice were 7-8 weel( old, VAF®, males of the Charles River Crl:CD-1 
(ICR)BR strain purchased from Charles River Breeding Laboratories (Raleigh, NC). 
The mice were group housed in suspended stainless steel cages over non-contact 
bedding. The murine pathogen-free environment was maintained with a 12 hour 
light/dark cycle at 72 ± 4® F and 50 ± 20% humidity. Purina Certified Rodent Chow 
5002 (Purina Mills Inc., Richmond, IN) and reverse osmosis water were provided 
ad libidum. The animals were conditioned for at least one week prior to treatment. 
LPS administration 
Mice were anesthetized in a desiccation chamber containing 
methoxyflurane (Metofane®, Pitman-Moore, Mundelein, IN). Once in a deep plane 
of anesthesia, mice were removed from the chamber and given an intranasal 
instillation of 50 |iL of sterile saline containing 50 p,g (1.0 mg/mL) LPS (from 
Escherichia coii Serotype 055:85, Sigma Chemical Co., St Louis, MO) and 4% 
monastral blue dye (Sigma) by placing the saline on the external nares of the 
anesthetized mouse until inhalation was observed. The monastral blue dye was 
added to the saline as a method of determining whether the inhalation was 
successful. 
Tissue coiiection and handling 
At 0 (untreated), 1,2,4, 6, and 24 hours after LPS instillation, 2 mice per 
time point were sacrificed via a lethal injection (0.2 mL IP) of Euthanasia 5 
Solution® (Henry Schein Inc., Port Washington, NY). Once moribund following the 
lethal injection, they were exsanguinated by aortic transection. The lungs were 
then inflated in situ with 0.8 mL of a solution containing 1/3 Tissue Tek OCT (Miles, 
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inc., Elkhart, IN) and 2/3 PBS by volume. A ligature was tied around the trachea. 
The lungs were removed from the thorax and Immersed in supercooled Isopentane 
for 10 seconds. The frozen, Inflated lungs were quickly sectioned , embedded in 
OCT compound In a cryomold, ànd snap frozen in supercooled isopentane to 
prevent thawing and subsequent collapse of the transected lungs. The OCT blocks 
were stored at -80°C. E-selectIn expression at the 4 hour time point was examined 
In greater detail. The lungs of an additional 6 treated mice were collected 4 hours 
after IN LPS by the above method. 
Immunohistochemlstry 
Cryostat sections (6-7 ^m) were air dried onto silane-coated slides (Cel-Tek 
Inc., Glenview, IL), fixed in cold (4°C) acetone for 5 minutes, and air dried again. 
The sections were stored at -20°C in sealed plastic packages until use. All 
subsequent steps were carried out at room temperature. Cryosectlons were 
rehydrated in phosphate buffered saline (PBS) for 15 minutes prior to a 30 minute 
incubation in 1% H2O2 in methanol to block endogenous peroxidase. The slides 
were loaded onto an automated immunostainer (Cadenza, Shandon Scientific Ltd., 
Runcorn, UK) for the remainder of the immunostaining procedure. The sections 
were allowed to react with 10% normal rabbit serum (diluted 1:10 in PBS) for 30 
minutes followed by 15 minutes each In avidin then blotin blocking solutions 
(Vector Laboratories, Burllngame, CA). Pilot studies revealed that the avidin and 
blotin blocking steps significantly decreased nonspecific staining. The monoclonal 
antibodies employed for the Immunostaining were anti-E- (MAb 9A9) and P-
selectin (MAb 10A10) and were provided by Dr. Barry Wolitzky (Dept. of 
Inflammation and Autoimmune Disease, Hoffmann-La Roche, Nutley, NJ). 
Irrelevant, class and Isotype matched rat MAbs were used in appropriate 
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concentrations as negative controls. Dilutions of the primary antibody were 
optimized in pilot experiments to be 10 p,g/mL in PBS containing 0.1% bovine 
serum albumin (BSA). Sections stained with iVIAb 9A9 or the irrelevant control 
were incubated for 2 hours; whereas, 10A10 and its control were incubated for 1 
hour. The primary MAbs were followed by a 30 minute incubation in a biotinylated 
rabbit anti-rat IgG (mouse adsorbed) (Vector Laboratories, Burlingame, CA) using 
50 p.L of the secondary antibody diluted in 10 mL of PBS containing 150 of 
normal rabbit serum. Then the slides were incubated for 30 minutes in the avidin-
biotin-peroxidase conjugate which was prepared as follows: 5 mL PBS mixed with 
25 g of non-fat powdered milk and two drops (100 ^L) each of bottle A and bottle B 
from the Vector Elite Kit (ABC Elite Kit, Vector Laboratories, Burlingame, CA). 
Antibody binding was visualized with 3,3'-dlaminobenzidine tetrahydrochloride 
(DAB) (ISOPAC®, Sigma Chemical Co., St. Louis, IVIO) mixed 1:2 with 35 |iL H2O2 
in 50 mL of distilled water and incubated for 5 minutes. The slides were then 
rinsed in water, counterstained with hematoxylin, dehydrated, cleared and 
coverslipped. 
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RESULTS 
E-selectin expression in the iungs of mice following treatment with IN LPS 
was detected using immunohistochemical staining with an anti-murine E-selectin 
MAb (9A9) (Fig. 1). Untreated control mice and mice examined at one hour post-
LPS treatment had no positive staining in the lungs. Animals in the 2 hour post-
treatment group had mild positive staining in endothelial cells lining arterioles and 
venules adjacent to bronchioles. Compared with staining in the 2 hour group, 
staining in the 4 and 6 hour groups had increased in terms of number of vessels 
involved and the intensity of staining (Table 1). The distribution of staining, 
however, remained the same, involving the arterioles and venules near ainways. In 
the 24 hour post-treatment group, staining was greatly decreased to very low or 
non-detectable levels. Peak staining, which was seen in the 4 and 6 hour groups, 
was patchy and involved a relatively small number of vessels (10-15 vessels/ lung 
section). Specificity of the staining was demonstrated by a lack endothelial 
staining in serial lung sections stained with an isotype matched rat anti-mouse 
MAb. 
Lungs of the control and IN LPS-treated mice were also stained with MAb 
10A10, an anti-murine P-selectin Ab (Fig. 1). Mild, constitutive P-selectin 
expression was seen in scattered vessels (capillaries, small veins, and venules) in 
lungs of untreated mice. This staining consisted of punctate foci within the 
cytoplasm of the endothelial cells. Between 1 and 6 hours post-treatment, staining 
had progressively increased to involve larger vessels, such as arteries and larger 
veins. In these groups, individual endothelial cells had a more diffuse surface 
staining rather than solely punctate, cytoplasmic staining seen in earlier groups. 
Staining in the 24 hour post-treatment group was very similar in intensity and 
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Figure 1. A, B: Lungs of untreated mice immunohistochemically (IHC) stained for 
E-selectin (A) and P-selectin (B). C, D, F: Lungs of mice treated 4 hours 
earlier with intranasal (IN) LPS IHC stained for E-selectin (C), P-selectin 
(D), and with an isotype-matched control antibody (F). E: Lungs from a 
mouse 24 hours after IN instillation of LPS IHC stained for E-selectin. 
IHC staining with monoclonal anti-murine E-selectin (9A9), P-selectin 
(10A10), and IL12-receptor (control) antibodies using aviding-biotin com­
plex (ABC) method, DAB chromogen, hematoxylin counterstain. (400X) 
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distribution to the basal staining seen in the untreated group. Overall, 3-5 fold 
more vessels stained positively for P-selectIn than for E-selectIn (Table 1). A 
notable difference between the expression of E- and P-selectIn detected In these 
studies was that capillaries, arteries and large veins were stained by P-selectin 
MAb but not E-selectin MAb. 
Table 1 
Comparison of E- and P-selectIn expression in mouse lungs 
following intranasal instillation of bacterial llpopolysaccharide (LPS) 
extent of vessel involvement type of vessels staining positive^ 
treatment E-selectin P-selectin E-selectin P-selectin 
0 (control) - + none capillaries, venules, and 
small veins 
1 - ++ none capillaries, venules, and 
small veins 
2 + +++ arterioles and venules 
near bronchioles 
capillaries, venules, veins 
and arterioles 
4 ++ +++++ arterioles and venules 
near bronchioles 
capillaries, venules, veins 
arterioles, and small 
arteries 
6 ++ ++++ arterioles and venules 
near bronchioles 
capillaries, venules, veins 
and arterioles 
24 + + arterioles and venules 
near bronchioles 
capillaries, venules, and 
small veins 
The extent of vessel involvement was examined in regions in which blue macrophages were 
present indicating delivery of LPS to that area. 
At least 10 fields were examined in each lung section. 
The criteria for extent of vessel involvement was: 
- = 0 positively stained vessels in the entire lung section 
+ = 0-2 positively stained vessels/200x field 
++ = 2-4 positively stained vessels/200x field 
+++ = 4-6 positively stained vessels/200x field 
++++ = 6-10 positively stained vessels/200x field 
+++++ = >10 positively stained vessels/200x field 
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The fixation method (OCT/PBS inflation followed by snap freezing before 
sectioning) used in these studies is a novel method of fixation developed in the 
pilot studies. This method resulted in good morphologic preservation and proper 
inflation of the lungs compared to other methods that were attempted. 
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DISCUSSION 
This study demonstrated the upregulatlon of E- and P-selectIn expression in 
the lungs of mice in response to an acute inflammatory stimulus (IN instillation of 
LPS) as demonstrated by immunohistochemistry and immunoprecipitation. This 
upregulatlon was rapid, occurring within 2 hours for E-selectin and 1 hour for P-
selectin. Upregulatlon peaked by 4-6 hours and returned to near baseline levels by 
24 hours post-treatment. Immunoprecipitation studies performed in the laboratory 
of Ms. Christine Norton (Dept. of Inflammation and Autoimmune Disease, 
Hoffmann-La Roche, Nutley, NJ) confirmed the immunohistochemical finding of 
approximately 5-fold more P-selectin than E-selectin staining. In these studies 3 
mice/group were treated with IN saline alone or saline containing LPS (as 
described above) and sacrificed 3 hours later. Pooled lungs from each group were 
metabolically labeled for 2 hours, detergent lysed, extracted, and 
immunoprecipitated with anti-E- (9A9) and anti-P-selectin (10A10) MAbs. 
The results presented here are consistent with the time course of E-selectin 
expression reported to occur in cultured human and murine endothelial cell lines, 
in which expression peaks 4-6 hours after cytokine or LPS stimulation and returns 
to basal levels by 24-48 hours post-stimulation (253, 5). The P-selectin results 
reported here are consistent with the reports of others. P-selectin is constitutively 
expressed and stored pre-formed in cytoplasmic granules of endothelial cells and 
platelets (253, 5). The punctate staining seen in this study is consistent with the 
basal constitutive presence of P-selectin within intracytoplasmic granules. The 
peak expression of P-selectin through the 4-6 hour time points supports recent 
reports of prolonged P-selectin expression in mice and dogs both in vitro and in 
wVo(131, 132, 133). 
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The presence of E- and P-selectin on the surface of endothelial cells in mice 
given IN LPS suggests that these molecules may play a role in the early 
recruitment of neutrophils In this model. However, endothelial cell adhesion 
molecule expression does not always correlate with neutrophil margination and 
extravasation (257). For example, expression of the adhesion molecules E-
selectin and vascular cell adhesion molecule 1 (VCAM-1) did not correlate with 
leukocyte adhesion in mice injected intraperitoneally with LPS (149). Therefore, 
the strategy of interfering with or blocking selectin-dependent interactions was 
used to study the functional role of selectlns in neutrophil recruitment. These 
experiments will be discussed in Part 3. 
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PART 3 
SELECTIN ANTAGONISTS IN MURINE MODELS 
OF ACUTE INFLAMMATION 
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ABSTRACT 
Adhesion molecules expressed on the surface of endothelial cells and 
leukocytes play a role in the recruitment of leukocytes to areas of inflammation. 
The relative importance of a particular adhesion molecule in leukocyte adherence 
to the endothelium can be examined in vivo with antagonists that block the 
adhesion pathway of interest in vitro. This study utilized antagonists to two 
members of the selectin family of adhesion molecules (E- and P-selectin) to 
examine their roles in the infiltration of neutrophils into sites of acute inflammation 
in two murine models of inflammation. Mice (n=4/group) were pretreated with 
intravenous injection of 200 jig (4 hour group) or 500 p,g (3 and 6 hour groups) of 
monoclonal antibody (MAb) 9A9, an anti-E-selectin MAb. Monoclonal Ab 9A9 did 
not block neutrophil influx into the peritoneal cavity of mice injected 
intraperitoneally (IP) with 1.0 mL thioglycollate as measured by the number of 
neutrophils lavaged from the peritoneal cavity of mice 3, 4, and 6 hours post-
treatment (as compared to pretreatment with IV saline or control MAb). Ah analog 
of the selectin ligand, acid Lewis X (acid Le*), was also used as an antagonist in 
this model using 8 mice/group and 4 equally divided IV doses of 50 ^g each. Two 
and 4 hours after the IP injection of 1.0 mL of thioglycollate, the number of 
neutrophils in the peritoneal lavage fluid was not reduced by acid Le* treatment. 
The role of E- and P-selectin was examined in a second model of acute 
inflammation using intranasal (IN) instillation of bacterial lipopolysaccharide (LPS). 
Neutrophil numbers in the bronchoalveolar lavage (BAL) fluid were used as the 
endpoint. Eight mice/group were pretreated with anti-E-selectin MAb (10E6) (200 
ng), anti-P-selectin MAb (10E10) (100 |ig), a combination of 10E6 and 10E10 
(respectively, 200 and 100 fxg each), sterile saline (0.2 mL), or control MAbs 
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(isotype and dose matched to 10E10 and 10E6) and sacrificed at 2 and 6 hours 
after the IN LPS. Two hours post-treatment, the MAb combination (10E6 and 
10E10) and anti-P-selectin (10E10) MAb alone significantly decreased the number 
of neutrophils In the BAL fluid. However, at 6 hours post-treatment, blocking of 
neutrophil recruitment was significant in the combination group and in the anti-E-
selectin (10E6 alone) group, while the P-selectin alone group did not show any 
significant blocking. The combination treatment was a significantly better blocker 
than the anti-E-selectin antibody alone. When acid Le^ was used as the antagonist 
in the same model, no blocking was seen at 2 or 6 hours post-treatment. In 
conclusion, these data Indicate that anti-E-selectin MAb did not block 
thioglycollate-induced peritoneal inflammation. Furthermore, P-selectin (but not E-
selectin) played a role in neutrophil influx into lungs in the IN LPS model at 2 
hours. However, by 6 hours post-treatment, E-selectin and P-selectin were both 
involved in this influx. The carbohydrate acid Le^ is not an effective antagonist of 
neutrophil influx at early time points in the IP thioglycollate model and IN LPS 
model in mice. 
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INTRODUCTION 
Neutrophils participate in the pathogenesis of a variety of acute inflammatory 
diseases by the release of non-specific activation products such as proteases and 
oxygen radicals, that can damage host tissues (2). Examples of these neutrophil-
mediated inflammatory conditions include ischemia-reperfusion injury (182) and 
adult respiratory distress syndrome (8). The recruitment of neutrophils to sites of 
inflammation involves several sequential steps: neutrophil rolling along the 
activated endothelium, neutrophil activation and firm adhesion to the vessel wall, 
and migration of neutrophils into the surrounding tissue (32). These events require 
the interaction of complementary adhesion molecules expressed on the surfaces of 
neutrophils and endothelial cells in inflammatory sites. 
Several adhesion molecules have been shown to have a role in neutrophil-
endothelial interaction. For example, endothelial cells can be activated to express 
E-selectin, a member of the selectin family of adhesion molecules, in response to 
interleukin-1 (IL-1), tumor necrosis factor-a (TNF), and bacterial iipopolysaccharide 
(LPS). In cultured endothelial cells, this expression begins within 1-2 hours after 
an inflammatory stimulus and peaks in approximately 6-8 hours (5). On the other 
hand, thrombin and histamine result in rapid expression (within a few minutes) of 
P-selectin (another member of the selectin family) on the surface of endothelial 
cells. E- and P-selectin bind to oligosaccharides, sialyl Lewis X (sLe*) and related 
carbohydrates, present on the surface of neutrophils. This interaction between the 
selectins and their carbohydrate (CHO) ligands is believed to mediate the rolling 
stage of neutrophil extravasation (5). 
Selectin-mediated rolling is followed by adhesive events between members 
of two other families of adhesion molecules, both of which are members of larger 
protein superfamilles: the immunoglobulins and integrins (3). More specifically, 
the P2 integrins on neutrophils bind to members of the immunoglobulin superfamily, 
ICAM-1 and 2, on the surface of activated endothelial cells. This integrin-
immunoglobulin interaction mediates the firm adhesion and transendothelial 
migration phases of neutrophil extravasation at sites of acute inflammation. 
A deficit in either the integrin/immunoglobulin or selectin/CHO system will 
result in impairmed emigration of neutrophils as demonstrated by human leukocyte 
adhesion deficiency I (LAD I), the congenital deficiency of functional leukocyte 
integrins, and leukocyte adhesion deficiency II (LAD II), the congenital absence of 
sLe* (42, 203). Individuals with either of these syndromes lack the ability to recruit 
normal numbers of neutrophils into areas of inflammation; therefore, they suffer 
from chronic infections without pus formation, despite elevated circulating 
neutrophil counts in the peripheral blood (203, 42) 
The clinical syndromes of individuals with LAD I and LAD II suggest that 
interference with the adhesion cascade, at any point, could result in decreased 
recruitment of neutrophils and consequently in attenuation of neutrophil-mediated 
tissue damage. Numerous studies involving animal models of inflammation have 
demonstrated both a decrease in neutrophil emigration into sites of inflammation 
and a decrease in tissue damage when monoclonal antibodies (MAb) that bind to 
functional epitopes of adhesion molecules ("blocking" antibodies) are given 
systemically prior to the inflammatory insult (6). In addition to MAb, other 
antagonists, such as prokaryotic peptides, CHO mimetics of the selectin ligands, 
and adhesion molecule-IgG chimeras, have been used to block neutrophil-
endothelial interactions and neutrophil-mediated injury (235, 239, 258). 
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While the Pg integrins and ICAM-1 and -2 have been extensively evaluated 
in animal models, relatively few in vivo studies have examined the role of E-
selectin in animal models of inflammation (6). Those published to date include rat 
models of IgG Immune complex-induced pulmonary Inflammation and glycogen-
induced chemical peritonitis and a primate asthma model. A significant reduction 
in the number of neutrophils in the peritoneal lavage fluid has been reported to 
occur when F(ab')2 fragments of an anti-E-selectin blocking MAb were injected 
intravenously (IV) into the rats several times during the course of the intraperitoneal 
(IP) glycogen experiment (238). Details of this experiment however, were not 
published. In addition, both neutrophil influx into the lungs and subsequent tissue 
injury were decreased by a variety of antagonists in a rat model of IgG immune 
complex-induced lung inflammation. Effective antagonists included MAb, E-
selectin-IgG chimeras, and derivatives of sLe* given systemically (238, 235, 239). 
MAbs to E-selectin have also been shown to block both the neutrophil influx and 
late airway obstruction in a primate asthma model (173). 
Transgenic mice deficient in the gene for P-selectin were generated to 
examine the role of P-selectin in murine inflammation. These mice have a 
defective influx of neutrophils into the peritoneum following IP thioglycollate. In this 
study, P-selectin appeared to mediate the influx of neutrophils only during the early 
time points (first few hours), after which, another adhesion mechanism appeared to 
take over as P-selectin became less important (135). Because P-selectin is 
expressed early in inflammation and E-selectin is expressed slightly later, E-
selectin is a potential candidate for the phase of inflammation which occurs after P-
selectin is apparently no longer a significant participant in neutrophil recruitment. 
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The primary goal of these studies was to examine the role of E-selectin in 
two murine models of inflammation: intranasal (IN) instillation of LPS and chemical 
peritonitis induced by IP injection of thioglycollate broth. Monoclonal antibodies 
that have been demonstrated to block E-selectln-mediated binding of neutrophils in 
vitro (256) were used for the studies. A second objective was to answer the 
question: If P-selectIn and E-selectin are sequentially important in neutrophil 
adhesive events, does blocking both adhesion molecules result in an additive 
reduction in the inflammatory infiltrate? Monoclonal antibodies against functional 
epitopes on P- and E-selectin were used alone and in combination to evaluate this 
hypothesis in the IN LPS model. A third objective was to study the effects of a CHO 
mimetic known as acid Lewis X (acid Le^) which was used as an antagonist in both 
the IP thioglycollate and IN LPS models of inflammation. The criterion used to 
evaluate the effectiveness of the antagonists was neutrophil infiltration into lavage 
fluid. 
Several technical details were important in these experiments. Intravenous 
injection of MAb can induce neutropenia by a variety of mechanisms, including 
activating leukocytes, inducing neutrophil aggregation, and activating the 
complement cascade. Therefore, if blocking is observed, it is important to 
demonstrate a lack of peripheral neutropenia which itself could cause a decrease 
in neutrophil emigration. In addition, endotoxin-free, isotype matched non-blocking 
MAbs were always used as negative controls in these experiments. 
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MATERIALS AND METHODS 
Anti-E-selectin MAb and acid Le* blocking studies in intraperitoneal 
thioglycollate model 
Mice 
The mice used for this study were 7-10 weel< old, VAF®, males of the 
Charles River Crl:CD-1 (ICR)BR strain purchased from Charles River Breeding 
Laboratories (Raleigh, NC). The mice were group housed in suspended stainless 
steel cages over non-contact bedding. The murine pathogen-free environment 
was maintained with a 12 hour light/dark cycle at 72 ± 4® F and 50 ± 20% humidity. 
Purina Certified Rodent Chow 5002 (Purina Mills Inc., Richmond, IN) and reverse 
osmosis water were provided ad libidum. The animals were conditioned for at 
least one week prior to treatment. 
Anti-E-selectin monoclonal antibodies 
Monoclonal antibodies, provided by Dr. B. Wolitzky (Dept. of Inflammation 
and Autoimmune Diseases, Hoffmann-La Roche), were generated as described in 
Norton eta!., 1993 (256). Briefly, a recombinant phage containing the structural 
exons for mouse E-selectin was isolated and characterized. The polymerase chain 
reaction (PCR) technique was used to fuse the lectin and epidermal growth factor­
like (EGF) domains of murine E-selectin to form an artificial cDNA which was 
expressed in eukaryotic cells. Transient expression in COS cells demonstrated 
that the lectin and EGF domains were sufficient to mediate the binding of mouse 
and human neutrophils as well as HL60 cells (a human myeloma cell line) to 
soluble E-selectin bound to a plate. Recombinant soluble murine E-selectin was 
purified and used to immunize rats to generate MAb specific for mouse E-selectin. 
A panel of MAbs directed against mouse E-selectin was characterized These 
included MAbs 9A9 and 10E10, which inhibit the adhesion of HL60 cells or mouse 
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neutrophils to COS cells expressing mouse lectin/EGF domains. While MAbs 2B11 
and 14D4 recognize murine E-selectin, but they do not block E-selectln-mediated 
binding. A Limulus amebocyte lysate Pyrotell® test kit (Associates of Cape Cod, 
Inc., Wood's Hole, MA) was used to establish that endotoxin levels in the MAb were 
<0.5 EU/mL. 
In the first experiment, mice were pretreated with either saline, blocking anti-
E-selectin MAb 9A9, or control MAb 2B11 prior to IP injection of 1.0 mL of 
thioglycollate. Antibody treatment was as follows: 0.2 mL of sterile saline alone or 
saline containing 200 mg of MAb was injected intravenously (IV) into the tail vein 5 
minutes prior to the IP injection of 1.0 mL of thioglycollate (n=4 mice/group). Four 
hours later, the animals were sacrificed. Subsequent experiments used a lower 
dose of IP thioglycollate (0.25 mL thioglycollate in 0.25 mL sterile saline). Control 
animals were pretreated (5 minutes prior to IP thioglycollate) with tail vein 
injections of 0.2 mL sterile saline alone or saline containing 500 mg of either 9A9 
or 14D4 (n=:3). Mice were sacrificed 3 and 6 hours later. 
Acid Lex 
Acid Le*. a carbohydrate analog of sLe* was provided by Dr. Donna Huryn 
(Dept. of inflammation and Autoimmune Diseases, Hoffmann-La Roche). A 
manuscript detailing the synthesis of this compound is in preparation. Mice were 
injected with 1.0 mL of thioglycollate and sacrificed 2 and 4 hours later. Because of 
the short half-life of carbohydrates in the blood, mice were treated with 200 mg of 
acid Le* in four equally divided doses throughout the experiment at the following 
intervals; 0 (immediately prior to the thioglycollate), 0.5, 1, and 1.5 hours for the 
group sacrificed at 2 hours post-treatment and at 0, 1, 2, and 3 hours for the group 
sacrificed at 4 hours post-treatment (n=4). The acid Le* was diluted in sterile saline 
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(50 mg acid Le* in 0.1 mL saline) and injected into the tail vein. Sterile saline (0.1 
mL) was injected alone, as a control, using the same regime as the acid Le^ (n=4). 
intraperitoneal thioglycollatQ and evaluation of peritoneal lavage fluid 
Mice were injected IP with 0.25 (with 0.25 mL sterile saline) or 1.0 mL of 
thioglycollate broth (Sigma Chemical Co., St. Louis, MO). Three, 4, or 6 hours 
later, mice were sacrificed via CO2 inhalation. After removing the skin overlying the 
peritoneum, 10 mL of Dulbecco's phosphate buffered saline (PBS) (Gibco 
Laboratories, Grand Island, NY) containing 10 U/mL of heparin was injected into 
the peritoneal cavity. The peritoneal wall was gently massaged prior to withdrawal 
of the lavage fluid through a 22 gauge needle. The yield of lavage fluid was 7-8 
mL/animal. The fluid was kept on ice in polypropylene tubes until evaluation 
(within 30 minutes). The total number of leukocytes in the lavage fluid was 
manually counted with a Neubauer hemacytometer. Cytocentrifuged cell 
preparations were made by centrifuging 100 ^L of peritoneal lavage fluid at 800 
rpm for 5 minutes on a Cytospin 2™ (Shandon Scientific Ltd., Runcorn, UK), then 
staining the cells with a modified Wright's stain on a Hematek™ autostainer (Miles 
Laboratories, Inc., Elkhart, IN). Two slides were made for each animal, and 
differential counts were done by counting 100 leukocytes/slide using a light 
microscope at 630x oil immersion. 
Statistics 
Data were analyzed by a one-way analysis of variance (ANOVA) for each 
time point. If significant differences were detected among group means, a 
Student's t-test was applied for comparison of group means. Statistical 
significance was applied when p<0.05. 
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Anti-E- and P-selectIn MAb and acid Le* blocking studies in intranasal 
LPS model 
Mice 
The mice used for this study were 7-8 week old, male, Charles River VAF® 
Crl:CD-1 (ICR)BR mice purchased from Charles River Breeding Laboratories 
(Raleigh, NC). The animais were housed and treated as described above. 
Monoclonal antibodies 
The blocking anti-E-selectin antibody (10E6, an lgG2b MAb) used for this 
study was generated as described (256). A panel of anti-murine-P-selectin 
antibodies was generated and screened in the same manner as the anti-E-selectin 
antibodies. A MAb, 5H1 (an lgGi MAb), which recognizes murine P-selectin and 
blocks murine neutrophil binding to activated endothelial cells, was used as the 
anti-P-selectin blocker. Control antibodies were irrelevant, isotype matched MAb 
(8G9 and 24A1). A Limulus amebocyte lysate Pyrotell® test kit was used to 
establish that endotoxin levels in the MAb preparations were <0.5 EU/mL. 
Experimental design 
There were 8 mice per group sacrificed at 2 and 6 hours after IN instillation 
of LPS. Five to 10 minutes prior to intranasal instillation of LPS, one of the 
following was injected intravenously into the retro-orbital sinus: (1) 0.2 mL sterile 
saline, (2) a combination of two control MAbs (100 mg MAb 8G9 and 200 mg MAb 
24A1 in 0.2 mL sterile saline), (3) a combination of anti-E- and P-selectin MAbs 
(100 mg MAb 5H1 and 200 mg MAb 10E6 in 0.2 mL sterile saline), (4) anti-E-
selectin MAb (200 mg MAb 10E6 in 0.2 mL sterile saline), or (5) anti-P-selectin 
MAb (100 mg MAb 5H1 in 0.2 mL sterile saline). Pilot studies conducted by Dr. Kim 
Mclntyre (Dept. of Inflammation and Autoimmune Disease, Hoffmann-La Roche) 
established these antibody doses as lOx the amount required for in vivo blocking. 
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Acid Lex 
Acid Le* was provided by Dr. Donna Huryn (Dept. of Inflammation and 
Autoimmune Disease, Hoffmann-La Roche). Mice were sacrificed 2 and 4 hours 
after intranasal instillation of 10 or 100 |ig LPS in 50 mL saline. Five animals per 
group/time point were treated with intravenous injections (in the lateral tail vein) of 
200 )j.g of acid Le* in four equally divided doses at the following intervals: 0 
(immediately prior to the thioglycollate), 0.5, 1, and 1.5 hours for the group 
sacrificed at 2 hours post-treatment and at 0, 1, 2, and 3 hours for the group 
sacrificed at 4 hours post-treatment. The acid Le* was diluted in sterile saline (50 
mg acid Le^ in 0.1 mL saline) and injected into the tail vein. Sterile saline (0.1 mL) 
was injected alone, as a control, using the same regime as the acid Le* (n=5). 
Intranasal instillation of LPS and evaluation of bronchoalveolar lavage fluid 
Mice were anesthetized in a desiccation chamber containing 
methoxyflurane (Metofane®, Pitman-Moore, Mundelein, IN). Once in a deep plane 
of anesthesia, mice were removed from the chamber and administered 50 mL of 
sterile saline containing 10, 50, or 100 ^ig LPS (from Escherichia coli Serotype 
055:85, Sigma Chemical Co., St Louis, MO) and 4% monastral blue dye (Sigma) 
by placing the saline on the external nares of the anesthetized mouse until 
inhalation was observed. Two and 6 hours later, mice were sacrificed via a lethal 
dose (0.2 mL IP) of Euthanasia 5 Solution® (Henry Schein Inc., Port Washington, 
NY). When deeply anesthetized, mice were exanguinated by aortic transection. 
Bronchoalveolar lavage (BAL) was performed by inserting an 18.5 gauge nylon 
catheter into a small tracheostomy opening of the exposed trachea. The trachea 
was secured to the catheter using 5-0 silk suture material. Lungs were lavaged in 
situ with a total of 4 mL of cold PBS containing 10 U/mL of heparin instilled in 5 
repeated lavages of 0.8 mL each. BAL fluid was put into polyethylene tubes and 
kept on ice until evaluation (within 30 minutes). Total leukocyte count in the BAL 
fluid was quantified with a Neubauer hemacytometer. Cytocentrifuged cell 
preparations were made by centrifuging 100 mL of BAL fluid at 800 rpm for 5 
minutes (Cytospin 2™) followed by staining the cells with a modified Wright's stain 
on a Hematek™ autostainer. Two slides were made for each animal, and 
differential counts were done by counting 100 leukocytes/slide using a light 
microscope at 630x oil immersion. 
Hematology 
Peripheral blood samples were collected from animals very shortly after the 
IP Euthanasia 5 Solution® was administered, at which point mice were mildly 
sedated. Retro-orbital sinus puncture with a capillary tube was used to collect 
blood into a tube containing EDTA which was shaken vigorously to distribute the 
EDTA and prevent coagulation. Clotted samples were discarded. An automated 
hematology analyzer (Coulter Counter Model S-Plus IV, Coulter Electronics, 
HIaleah, PL) was used to determine a peripheral white blood cell count on the 
anticoagulated whole blood which was also used to make peripheral blood 
smears. The smears were stained with a modified Wright's stain on a Hematek™ 
autostainer and differential white blood cell counts were done by counting 100 
leukocytes per smear. Abnormal cellular morphology was noted. 
Statistics 
Data were analyzed by a one or two-way analysis of variance (ANOVA) for 
each time point. Since experiments often spanned more than one day, a block 
design was employed to rule out the effect of date on the statistical model. If 
significant differences were detected among group means, a Student's t-test was 
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applied for comparison of group means. Statistical significance was applied wlien 
p<0.05. 
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RESULTS 
Intraperitoneal thioglycollate 
Blocking with antl-E-selectin MAb 
Four hours after IP injection of 1.0 mL of thioglycollate, there was no 
statistically difference between absolute numbers of neutrophils in the peritoneal 
lavage fluid of mice pretreated with saline, control MAb 2B11, or blocking MAb 9A9 
(Table 1) To further examine whether 9A9 could block neutrophil influx in this 
model, a lower dose of IP thioglycollate was used (0.25 mL thioglycollate in 0.25 
mL sterile saline) with the hypothesis that a lower grade inflammation may be 
easier to block. This study looked at time points 3 and 6 hours after the IP 
thioglycollate and used the control MAb 14D4. The results of this experiment, as 
summarized in Table 2, demonstrate that at both doses of thioglycollate, there was 
no difference between the treatment groups. The results of the MAb blocking 
studies in the IP thioglycollate model demonstrated that blocking E-selectin alone 
at these early time points has no effect on the influx of neutrophils into the 
peritoneum, as measured by absolute neutrophil numbers in the peritoneal lavage 
fluid. 
Blocking with acid Lex 
To examine the potential ability of a carbohydrate analog of the selectin 
ligand sLe^ known as acid Le^, four divided doses of acid Le* were given over the 
course of an IP thioglycollate experiment with a 2 and 4 hour time of sacrifice. 
Table 3 summarizes the results of these experiments which demonstrate that, at 
both 2 and 4 hours after treatment with IP thioglycollate, acid Le^ did not decrease 
the number of neutrophils in the peritoneal lavage fluid. There were four 
mice/treatment group/time point; however, one animal in the 4 hour acid Le*-
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Table 1 
Effect of MAb 9A9 on the high-dose IP thloglycollate-lnduced 
peritoneal inflammation at 4 hours post-treatment 
animai# treatment 
total wbc 
(xlO^/mL) in 
peritoneal lavage 
% PMN in 
peritoneal 
lavage 
PMN(x10*/mL) 
in peritoneal 
lavage 
mean PMNxlO^/mL 
(± s.d.) 
for each treatment group 
1 saline 80.0 78.0 62.40 
2 saline 93.0 77.5 72.07 59.3 (11.6) 
3 saline 77.0 76.0 58.52 
4 saline 71.0 62.0 44.02 
5 9A9 60.3 62.0 37.39 
6 9A9 58.0 59.0 34.22 53.7 (24.1) 
7 9A9 124.0 70.0 86.80 
8 9A9 72.0 78.5 56.52 
9 2B11 127.0 70.0 88.90 
10 2811 118.0 78.0 92.04 71.2 (25.3) 
11 2B11 55.5 67.0 37.19 
12 2B11 98.5 67.5 66.49 
9A9 is a rat anti-mouse E-selectin monoclonal antibody which blocks neutrophil binding in 
vHro 
2B11 is an isotype-matched rat anti-mouse E-selectin monoclonal antibody 
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Table 2 
Effect of MAb 9A9 on the low dose IP thloglycollate-induced 
peritoneal Inflammation at 3 and 6 hours post-treatment 
treatment time of sacrifice 
Pti/IN xlO^/mL 
(± s,d.) 
saline 47.6 (29.9) 
9A9 3 hours 52.2 (8.1) 
14D4 39.9 (7.8) 
saline 63.1 (11.0) 
9A9 6 hours 69.4 (13.9) 
14D4 77.9 (28.9) 
9A9 is a rat anti-mouse E-selectin monoclonal antibody which blocks neutrophil binding in 
vitro 
14D4 is an isotype-matched rat anti-mouse E-selectin monoclonal antibody 
n=3 mice/group 
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Table 3 
Effect of treatment with acid Le* on IP thloglycollate-lnduced 
peritoneal Inflammation at 2 and 4 hour time points 
treatment (n=8/group) time of sacrifice PMNx10*/mL (± s.d.) 
saline 2 hours 21.7(4.5) 
acid Le* 2 hours 21.6 (7.8) 
saline 4 hours 66.8 (8.5) 
acid Le* 4 hours 64.9 (29.3) 
treated group suffocated during the IV injection, a rare complication of the restraint 
procedure. This made n=3 for that group. 
Intranasal LPS 
Blocking with anti-E- and P-seleotin MAb 
Two hours after the Intranasal instillation of LPS, both the combination of 
anti-E- and anti-P-selectin IVIAbs and anti-P-selectin MAb alone resulted in a 
significant decrease In the neutrophil numbers In the BAL fluid (Fig. 1). By 6 hours 
post-treatment, the combination of anti-E- and anti-P-selectin MAbs and anti-E-
selectin MAb alone resulted in a significant decrease in this parameter. 
Interestingly, at 6 hours post-treatment, the combination antibody treatment was 
significantly different from the anti-E-selectin MAb alone (Fig. 1). These results 
suggest that P-selectin alone is important for the neutrophil influx into the lungs in 
the early phases of Inflammation in this model; while in later time phases, both E-
and P-selectin are involved in the recruitment of neutrophils. 
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Figure 1. Effect of pre-treatment with blocl<ing MAb on the number of neutrophils in 
BAL fluid of mice receiving IN LPS 2 hours (A) and 6 hours (B) earlier. 
Statistically significant groups are indicated by ** (p<0.01) and * 
{p<0.05). n=8 mice per group. 
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Hematology 
Treatment with the MAb alone or in the various combinations did not result in 
peripheral neutropenia at either time point (Fig. 2). It is interesting to note, 
however, that the mice receiving both anti-E- and anti-P-seiectin MAb had an 
elevation in the numbers of circulating neutrophils in blood collected from the infra­
orbital sinus at the time of sacrifice. This elevation was statistically significant at 
p<0.05 in the 6 hour group but not in the 2 hour group. This increase in circulating 
neutrophils lil<ely reflects a change in neutrophil pools as a consequence of the 
blockade of the neutrophil influx into the inflamed lungs. 
1 
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Figure 2. Neutrophil numbers in the peripheral blood collected at the time of 
sacrifice. Mice were pretreated with MAb or saline, given an IN 
instillation of LPS, then sacrificed 2 and 6 hours later. n=8 mice/group. 
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Blocking with acid Lex 
There was no significant difference between the numbers of neutrophils in 
the BAL fluid of the acid Le* or saline groups at 2 or 4 hours post-treatment with 
either dose of IN LPS (Fig. 3). These results indicate that acid Le* does not reduce 
the early neutrophil influx into the lungs of mice treated with IN LPS. 
< 40-
Ç 20-
• saline 
• acid Le* 
2 hours 
10 100 
4 hours 
IN LPS dose (ixg) 
Figure 3. Effect of IV acid Le* or saline treatment on neutrophil count in the BAL 
fluid of mice receiving two doses (10 and 100 ^g/mouse) of IN LPS at 2 
and 4 hours post-treatment. n=5 mice/group. 
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DISCUSSION 
These studies demonstrate the overlapping functions of E- and P-selectin in 
recruitment of neutrophils into sites of inflammation in the mouse. Blocking E-
selectin alone failed to significantly reduce the influx of neutrophils into the 
peritoneal cavity in the IP thioglycollate model; while in the IN LPS model, blocking 
E-selectin reduced neutrophil infiltrates at 6 hours post-treatment but not at 2 hours. 
In comparison, significant blocking was seen 2 hours post-treatment with the anti-
P-selectin antibodies. Similar blocking was observed in the double antibody 
blocking studies at the 2 hour time point suggesting P-selectin alone is responsible 
for the selectin-mediated recruitment of neutrophils by the activated endothelium at 
early stages of inflammation. This finding is in complete agreement with those in 
transgenic mice deficient in the gene for P-selectin, which demonstrated a role for 
P-selectin in leukocyte interactions with endothelium in the early phase of 
leukocyte recruitment into inflammatory sites (135). Interestingly, 6 hours post-
treatment, both E- and P-selectin were important in neutrophil influx into the BAL 
fluid of mice treated with IN LPS. Anti-E-eelectin MAb blocked approximately 20% 
while the combination of anti- E- and P-selectin MAb blocked 65% of the 
neutrophilic infiltrate in the IN model 6 hours post-treatment. These data suggest 
that P-selectin alone mediates the influx at 2 hours post-treatment. By 6 hours 
post-treatment, E-selectin is more important than P-selectin although P-selectin still 
plays an additive role in selectin-mediated binding of neutrophils to the 
endothelium in sites of inflammation as reflected by the effectiveness of the 
combined E- and P-selectin MAb blocking. 
In these studies, acid Le^, the carbohydrate analog of the selectin ligand, 
sLex, failed to block infiltration of neutrophils into either the peritoneum of mice 
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following IP thioglycollate or the lungs following IN instillation of LPS. In vitro 
studies have demonstrated that acid Le^ is equivalent to sLe^ in its ability to inhibit 
binding of human PMN or HL60 cells (a myeloid leukemia cell line) to recombinant 
soluble E-selectin (Dr. Bob Campbell, Dept. of Inflammation and Autoimmune 
Disease, Hoffmann-La Roche, unpublished results). However, the IC50 
(concentration at which 50% of the binding is inhibited) of these carbohydrates is in 
the low m M range which is orders of magnitude lower than that for blocking MAbs. 
Moreover, carbohydrates usually have a very short half-life in the serum. The 
blood levels of acid Le* could not be measured in these studies due to the lack of 
an assay to evaluate them. Nevertheless, the recent publication of the structure of 
crystallized E-selectin demonstrates that the amino acid side chains involved with 
the carbohydrate binding are on the surface of the molecule (259). The low affinity 
of the soluble carbohydrates for these surface residues may explain the lack of 
blocking ability due to the high shear forces encountered within blood vessels. In 
vivo, the carbohydrate ligands for the selectins are clustered on protein scaffolds 
which increases the avidity of the selectin-carbohydrate interactions (261). In 
conclusion, the inability of acid Le^ to block the neutrophil influx in the IP 
thioglycollate and IN LPS models is thought to demonstrate a lack of in vivo 
efficacy for this soluble, monomeric carbohydrate analog of sLe* rather than a lack 
of E- or P-selectin involvement in the recruitment of the neutrophils. 
The increase in the circulating neutrophils in the peripheral blood of animals 
given IN LPS in the double blocking antibody groups is interpreted to result from 
the inability of these cells to leave the blood stream because of the antibody 
blockade. Similarly, at 2 hours post-treatment, the anti-P-selectin IVIAb could 
significantly block neutrophil extravasation and also caused an increase in 
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peripheral blood neutrophils. Work by Dr. Kim IVIclntyre (Dept. of Inflammation and 
Autoimmune Diseases, Hoffmann-La Roche) has established the linl< between 
blocking neutrophil extravasation and the increase in circulating PMN 
(unpublished data). Following the same antibody dosing regime established by 
the studies presented here but without an inflammatory stimulus, blood was 
collected at 2 and 6 hours after the antibody treatment. This work showed that in 
the absence of inflammation, there was no increase in circulating numbers of 
neutrophils in the antibody treatment groups relative to the saline group at either 
time point. Further work by others at Hoffmann-La Roche support the results seen 
in the IN LPS double antibody blocking study (unpublished results). These 
experiments used the blocking regime of E- and P-selectin MAb alone and in 
combination in the IP thioglycollate model and demonstrated that P-selectin was 
important at early time points in mice given IP thioglycollate but both E-selectin and 
P-selectin were important at later time points. 
Adhesion molecule pathways have a great deal of redundancy leading to 
overlap of function between the various adhesion molecules. "Knocking out" the 
function of one selectin can be compensated for by one or more of the other 
selectins. This study demonstrates the overlap in function between the endothelial 
cell selectins, E- and P-selectin, in the recruitment of neutrophils to the lung in the 
IN LPS model in the mouse. This overlap may be peculiar to mice since blocking 
of E-selectin alone has been demonstrated to block neutrophil influx into sites of 
acute inflammation in other species (238, 240). However, few in vivo studies have 
addressed the overlapping roles of E- and P-selectin, so this principle of 
redundancy may not be unique to the mouse. The findings reported here suggest 
that therapies directed at the selectins in neutrophil-mediated diseases should be 
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aimed at blocking the common ligand rather than at each of the selectins alone. 
However, carbohydrate analogs with higher avidities will need to be synthesized 
for in vivo efficacy. 
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PART 4 
E-SELECTIN DEFICIENT TRANSGENIC MICE 
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ABSTRACT 
E-selectin is an adhesion molecule expressed on the surface of activated 
endothelial cells in areas of inflammation. In vitro studies and studies in rats and 
primates have demonstrated that E-selectin plays a role in the recruitment of 
leukocytes, including neutrophils, to areas of acute inflammation. The goal of these 
studies was to investigate the phenotype of transgenic mice deficient in the gene 
for E-selectin. Macro- and microscopic examination of tissues and organs revealed 
no difference between 3 transgenic mice deficient in the gene for E-selectin 
(generated by gene targeting in embryonic stem cells) and 3 wild-type, line-
matched mice. Immunohistochemical staining confirmed the absence of protein on 
endothelial cells in the heart and lungs of E-selectin deficient (knockout) mice 
following systemic treatment with bacterial lipopolysaccharide. Circulating levels of 
neutrophils in the peripheral blood of knockout mice were higher than, but not 
statistically different from, neutrophil counts in the circulation of the wild-type mice. 
E-selectin knockout mice had a decreased ability to recruit neutrophils to an area of 
acute inflammation as indicated by decreased numbers of neutrophils in the 
peritoneal lavage following intraperitoneal (IP) injection of thioglycollate. This 
decrease was small, however, and was not statistically significant. These knockout 
mice represent a novel animal system in which to evaluate the role of E-selectin in 
murine inflammatory responses. The studies presented here demonstrate that the 
knockout mice develop normally and may have an only mildly impaired 
inflammatory response in the IP thioglycollate model of inflammation. 
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INTRODUCTION 
E-selectin, a member of the seleotin family of leukocyte-endothellal cell 
adhesion molecules, is expressed on the surface of activated endothelial cells in 
areas of acute inflammation. In vitro, its expression on cultured endothelial cells 
peaks within 4-6 hours of stimulation by interleukin-1 (IL-1), tumor necrosis factor-a 
(IMF), or bacterial lipopolysaccharide (LPS) where it can support binding of 
neutrophils, monocytes, eosinophils, basophils, and a subpopulation of memory T 
cells (3, 5). Little work has been done to define the role of this adhesion molecule 
in vivo (6). 
Transendothellai migration of leukocytes begins with leukocyte rolling, 
followed by firm attachment of activated leukocytes to the endothelium and finally 
migration across the endothelium (31). There are three families of adhesion 
molecules involved in these three steps: the selectins, members of the 
immunoglobulin superfamily, and the leukocyte integrins. The selectins and their 
carbohydrate ligands mediate the rolling stage of transendothellai migration, while 
the immunoglobin superfamily members and their ligands, the leukocyte integrins, 
mediate the firm attachment and transendothellai migration stages (3). Disruption 
of any of these steps can block the extravasation of leukocytes into an inflammatory 
site (6). 
Two interesting conditions exist in humans which underscore the importance 
of the endothellal-leukocyte adhesion molecules in normal inflammatory 
processes. These conditions, known as leukocyte adhesion deficiency I (LAD I) 
and leukocyte adhesion deficiency II (LAD II), are characterized by an inability to 
recruit neutrophils into sites of inflammation with a resultant clinical syndrome of 
chronic infections without pus formation despite elevated circulating neutrophil 
counts in the peripheral blood (203, 42). A different mechanism underlies the 
altered inflammatory response in these two syndromes. LAD I is the result of a 
defect in the synthesis of the CD 18 subunit of the leukocyte integrins such that the 
stable adherence and transendothelial migration phases of leukocyte 
extravasation are unable to occur. On the other hand, LAD II affects the rolling 
phase because it results from a defect in the synthesis of the carbohydrate ligand 
for the selectins. Both conditions illustrate that interference with any phase of 
neutrophil extravasation can block neutrophils from entering an area of 
inflammation. 
Transgenic mice deficient in the gene for intercellular adhesion molecule-1 
(ICAM-1, a member of the Immunoglobulin superfamily) and P-selectin (a member 
of the selectin family) have been used to study the role of these two adhesion 
molecules in in vivo models of inflammation. They represent novel test systems in 
which to do these studies. Mice deficient in ICAM-1 exhibited impaired neutrophil 
emigration in response to IP thioglycollate and decreased contact hypersensitivity 
to 2,4-dinitrofiuorobenzene (68). P-selectin knockout mice have decreased rolling 
of neutrophils in the venules of exteriorized mesentery and diminished neutrophil 
influx into the peritoneal cavity in the early phases of inflammation induced by IP 
thioglycollate (135). 
Mice deficient in the gene for E-selectin were generated with the goal of 
using them as an in vivo test system in which to evaluate the role of E-selectin in 
inflammation. The following studies were designed to characterize the phenotype 
of these mice by a histologic survey of organs, immunohistochemical staining of 
hearts and lungs following systemic lipopolysaccharide (LPS) to confirm the lack of 
E-selectin expression, and by peripheral leukocyte counts. In addition, the role of 
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E-selectin in the recruitment of neutrophils into the peritoneal cavity following IP 
Injection of thioglycollate broth was evaluated using these novel mice. 
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MATERIALS AND METHODS 
Mice 
Transgenic mice deficient in the gene for E-selectin (knockout) were 
generated and provided by Dr. Mark Labow (Dept. of Molecular Sciences, 
Hoffmann-La Roche). These mice were produced by gene targeting using 
homologous recombination in embryonic stem cells, a widely used technique for 
altering the murine genome (262). The null allele was verified by RNA analysis 
[Using Northern blots and reverse transcriptase-polymerase chain reaction (RT-
PCR)]. The only E-selectin message detected by RT-PCR was a fusion RNA with 
the neo insert, as expected. Mice were housed in polycarbonate shoe-box caging 
with filter tops on certified 1/4" Bed-O-Cob (Anderson Industrial Products, Maumee, 
OH) bedding in a rodent pathogen-free environment. Picolab Mouse Diet 20 
#5058 (Purina Mills Inc., Richmond, IN) and reverse osmosis water via a water 
bottle were provided ad libidum. 
Histopathologic survey 
Complete necropsies were performed on 4 week old, male and female, 
knockout (KO, -/-) and line-matched control mice (wild type, wt, +/+) (n=:3/group) 
which were sacrificed by CO2 inhalation and immediately exsanguinated by aortic 
transection. The following tissues were immersion fixed in 10% neutral buffered 
formalin: kidney, liver, spleen, brain, thymus, lungs (inflated with 0.6 mL formalin), 
heart, stomach, intestines, and pancreas. After fixation, tissues were trimmed in a 
standard manner, embedded in paraffin, sectioned, and stained with hematoxylin 
and eosin (H&E) for routine histologic examination. 
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Peripheral blood leukocyte counts 
Peripheral blood samples were collected from 5 male and 5 female mice, 6-
8 weeks old, of both KO and wt genotype following sedation by CO2 inhalation. 
Retro-orbital sinus puncture with a capillary tube was used to collect blood into a 
tube containing EDTA (which was shaken vigorously to distribute the EDTA and 
prevent coagulation). Clotted samples were discarded. An automated hematology 
analyzer (Coulter Counter Model S-Plus IV, Coulter Electronics, Hialeah, FL) was 
used to determine a peripheral white blood cell count on the anticoagulated whole 
blood which was also used to make peripheral blood smears. The smears were 
stained with a modified Wright's stain on a Hematek™ autostainer (Miles 
Laboratories, Inc., Elkhart, IN) and differential white blood cell counts were done by 
counting 100 leukocytes per smear. Cellular morphology was evaluated. 
Immunohlstochemlstry 
Four hours after IP injection of 1 mL of sterile saline containing 100 |ig (0.1 
mg/mL) LPS (from Escherichia coii Serotype 055:65, Sigma Chemical Co., St. 
Louis, MO), three KO and three wt mice (7-8 week old, males) were sacrificed via a 
lethal injection (0.2 mL IP) of Euthanasia 5 Solution® (Henry Schein Inc., Port 
Washington, NY). Once moribund, they were exsanguinated by aortic transection. 
The lungs were then inflated in situ with 0.8 mL of a solution containing 1/3 Tissue 
Tek OCT (Miles, Inc., Elkhart, IN) and 2/3 PBS by volume. A ligature was tied 
around the trachea. The lungs were removed from the thorax and immersed in 
supercooled isopentane for 10 seconds. The frozen, inflated lungs were quickly 
sectioned, embedded in OCT compound in a cryomold, and snap frozen in 
supercooled isopentane to prevent thawing and subsequent collapse of the 
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transected lungs. Sections of the heart, and kidney were also embedded in OCT in 
cryomolds and snap frozen. The OCT blocks were stored at -80°C. 
Cryostat sections (6-7 ^m), air dried onto sllane coated slides (Cel-Tek Inc., 
Glenview, IL), were fixed In cold (4°C) acetone for 5 minutes and air dried again. 
The sections were stored at -20°C in sealed plastic packages until use. All 
subsequent steps were carried out at room temperature. Cryosectlons were 
rehydrated in phosphate buffered saline (PBS) for 15 minutes prior to a 30 minute 
incubation in 1% H2O2 in methanol to block endogenous peroxidase. The slides 
were loaded onto an automated immunostainer (Cadenza, Shandon Scientific Ltd., 
Runcorn, UK) for the remainder of the immunostaining procedure. The sections 
were allowed to react with 10% normal rabbit serum (diluted 1:10 in PBS) for 30 
minutes followed by 15 minutes each in avidin then blotin blocking solutions 
(Vector Laboratories, Burlingame, CA). Pilot studies revealed that the avidin and 
biotln blocking steps significantly reduced nonspecific staining. The monoclonal 
antibody (MAb) employed for the immunostaining was an anti-E-selectin (MAb 
9A9) antibody provided by Dr. Barry Wolitzky (Dept. of Inflammation and 
Autoimmune Disease, Hoffmann-La Roche). An irrelevant, isotype matched rat 
MAb was used at the same concentration as a negative control. Dilutions of the 
primary antibody were optimized in pilot experiments to be 10 ^ig/mL in PBS 
containing 0.1% bovine serum albumin (BSA). Sections were incubated with MAb 
9A9 or the irrelevant control for 2 hours. The primary MAbs were followed by a 30 
minute incubation in a biotinylated rabbit anti-rat IgG (mouse adsorbed) (Vector 
Laboratories, Burlingame, CA) using 50 ^L of the secondary antibody diluted in 10 
mL of PBS containing 150 |iL of normal rabbit serum. Then the slides were 
incubated for 30 minutes in the avidin-biotin-peroxidase conjugate which was 
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prepared as follows: 5 mL PBS mixed with 25 g of non-fat powdered milk and two 
drops (100 (xL) each of bottle A and bottle B from the Vector Elite Kit (ABC Elite Kit, 
Vector Laboratories, Burlingame, OA). Antibody binding was visualized with 3,3'-
diaminobenzidine tetrahydrochloride (DAB) (ISOPAC®, Sigma Chemical Co., St. 
Louis, MO) mixed 1:2 with 35 |iL HgOg in 50 mL of distilled water and incubated for 
5 minutes. The slides were then rinsed in water, counterstained with hematoxylin, 
dehydrated, cleared and coverslipped. 
Thioglycoliate-induced peritoneal inflammation 
The following experiment was performed on two different days. Mice in trial 
1 were 6 weeks old and Included randomly mixed numbers of males and females. 
Trial 2 had two males and two females per treatment group and were 7-9 weeks 
old. Knockout and line-matched control mice were injected IP with 1.0 mL of 
thioglycollate broth (Sigma Chemical Co., St. Louis, MO). At 2, 4, 6, and 8 hours 
post-treatment, 8 control and 8 KO mice were sacrificed by CO2 inhalation. After 
removing the skin overlying the peritoneum, 8 mL of Dulbecco's phosphate 
buffered saline (PBS) (Gibco Laboratories, Grand Island, NY) containing 10 U/mL 
of heparin was injected into the peritoneal cavity. The peritoneal wall was gently 
massaged prior to withdrawal of the lavage fluid through a 23 gauge needle. 
Yields of lavage fluid were between 5-6 mL/animal. Lavage fluid was kept on ice in 
polypropylene tubes until evaluated (<30 minutes). The total number of cells in the 
lavage fluid was manually counted with a Neubauer hemacytometer. 
Cytocentrifuged cell preparations were made by centrifuging 100 ^L of peritoneal 
lavage fluid at 800 rpm for 5 minutes on a Cytospin 2™ (Shandon Scientific Ltd., 
Runcorn, UK) then staining the cells with a modified Wright's stain on a Hematek™ 
autostainer (Miles Laboratories, Inc., Elkhart, IN). Two slides were made for each 
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animal, and differential counts were done by counting 100 leul<ocytes/slide using a 
light microscope at 630x oil immersion. 
Statistics 
Data were analyzed by a two-way analysis of variance (ANOVA). Since 
experiments spanned two days, a block design was employed to include the effect 
of date on the statistical model. A log transformation was done to determine if 
statistical significance could be applied to the transformed numbers. Treatment 
groups (ie: KO vs. line-matched controls) were compared at each time point using 
the Student's t-test. Statistical significance was applied when p<0.05. 
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RESULTS 
Histopathologic survey 
There was no difference histologically between the 3 transgenic mice 
deficient in the gene for E-selectin and the 3 line-matched controls in the following 
tissues: kidney, liver, spleen, brain, thymus, lungs, heart, stomach, intestines, and 
pancreas. At the time of necropsy, all organs were of normal size, appearance, 
and position. Therefore, the mice appeared to develop normally. 
Peripherai blood leukocyte counts 
Within each sex and overall, the mice deficient in the gene for E-selectin 
appeared to have higher numbers of neutrophils circulating in the peripheral blood 
relative to the line-matched control mice (Fig. 1), although the difference between 
these groups was not statistically significant (p<0.5). However, the small number of 
animals examined (n=5) may have precluded proper evaluation of this parameter 
in this study. 
Immunohistocliemical confirmation of tiie E-seiectin-deficient 
phenotype 
Three each of E-seiectin-deficient and line-matched control mice were injected IP 
with 100 |xg of LPS four hours earlier, sacrificed, and necropsied to collect and 
snap-freeze sections of the lungs, heart, and kidney. Frozen sections were 
immunohistochemically stained with MAb 9A9 (rat anti-murine E-selectin MAb). 
The knockout mice had no staining of the heart, lung, or kidney with anti-E-selectin 
MAb 9A9. In contrast, a significant amount of staining was present in the tissue of 
line-matched control mice. The positive staining was observed in the endothelium 
lining the atria and on the heart valves, in capillaries of the 
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Figure 1. Comparison of absolute neutropliil counts in the peripheral blood of mice 
deficient in the gene for E-selectin (KO) and line-matched control (wt) 
mice. 
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myocardium, and in scattered smail veins and venules in the lungs (Fig. 2). It is 
interesting to note that this expression was not associated with neutrophil 
margination or emigration. Kidneys failed to stain with the MAb in both KO and wt 
mice. The specificity of staining was demonstrated by the lack of staining by an 
isotype matched rat anti-mouse MAb (negative control MAb) in serial sections of 
heart, lung, and kidney. 
Effect of E-selectin deficiency on neutrophil influx into Inflamed 
peritoneal cavity 
Thioglycollate broth was injected into the peritoneal cavity of wild-type and 
E-selectin deficient mice. Two, 4, 6, and 8 hours later, the mice were sacrificed and 
peritoneal lavages were performed to assess whether the absence of E-selectin 
would result in an Inability of the KO mice to recruit neutrophils to an acute 
inflammatory site. At the 2 hour time point, KO and wt mice had essentially the 
same number of neutrophils in the peritoneal lavage fluid (Fig. 3). Although there 
was an apparent decrease in the mean neutrophil counts in the peritoneal lavage 
fluid of KO mice at the other time points, the difference was not statistically 
significant at any time point (Fig. 4). There was a significant difference between the 
KO and the wt mice at p<0.05 when all timepoints were pooled for analysis. 
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DISCUSSION 
These studies demonstrate that transgenic mice deficient in the gene for E-
selectin did not exhibit statistically significant phenotypic alterations in tissue 
morphology, circulating leukocyte counts, or neutrophil recruitment to sites of acute 
inflammation. This is in contrast to the increased numbers of circulating leukocytes 
and impaired neutrophil emigration in response to IP thiogiycoilate reported in 
transgenic mice deficient in the genes for both P-seiectin and ICAM-1 (135, 68). 
However, the lack of a significant defect in the inflammatory response agrees with 
monoclonal antibody (MAb) blocking studies in which an anti-E-selectin MAb with 
in vitro blocking activity failed to decrease the influx of neutrophils into the 
peritoneal cavity following IP thiogiycoilate (see Part 3 of this dissertation). 
Immunohistochemical staining verified the lack of E-selectin protein 
expression on the surface of activated endothelial cells in the KO mice indicating 
that the lack of obsen/able phenotypic changes was not due to a lack of fully null 
alleles (-/-). An absence of E-selectin protein expression was also confirmed by 
immunoprecipitation studies of heart and lung extracts from mice injected 4 hours 
earlier with IP LPS (C. Norton, personal communication). 
The E-selectin KO mice were fertile, viable, of normal size, and had macro-
and microscopically normal tissue and organ development demonstrating that E-
selectin is not required for normal development of the tissues examined. While E-
selectin potentially could play a role in development, it clearly is not essential. 
Although there was no statistical difference in neutrophil counts in the 
circulating blood and the neutrophil influx into the peritoneal cavity following IP 
thiogiycoilate between the groups in this study, there was an apparent trend as 
measured by these parameters. Circulating neutrophils were mildly increased in 
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the KO mice of both sexes relative to the wt mice of the same sex. In addition, the 
4, 6, and 8 hour post-IP thioglycollate groups had a modest decrease in the influx 
of neutrophils Into the peritoneal cavity. A difficulty encountered in these studies 
was related to the extreme novelty of these mice which resulted in a lack of sex-
and age-matched animals and the availability of few animals. Poor matching of 
animal age and sex may have resulted in high standard deviations, which would 
necessitate the use of high numbers of animals (which were not available) to attain 
statistical significance. Perhaps with a larger number of animals in the study 
groups, these trends would have had statistical significance. Studies by Dr. Kim 
Mclntyre (personal communication) using anti-P-selectin MAbs in wt vs. KO mice 
have demonstrated a decrease in neutrophil numbers in the peritoneal lavage of 
KO mice treated with the blocking MAb following IP injection of thioglycollate. 
Similar results, including decreased neutrophil influx and edema, were found in a 
model of delayed-type hypersensitivity in the ears of mice in which an anti-P-
selectin MAb was given to KO mice. Further studies are planned as animals 
become available, including using blocking anti-P-selectin MAb in the transgenic 
mice in a model of intranasal instillation of bacterial lipopolysaccharide. In 
addition, circulating neutrophil numbers will be measured in additional, older 
animals that are of interest because transgenic mice deficient in the gene for GDI 8 
did not have consistent elevations in peripheral neutrophil counts until the mice 
were 10-14 weeks old (50). In conclusion, although these studies had limitations, 
they suggest a mild deficit In recruitment of neutrophils into the peritoneum of E-
selectin knockout mice following IP instillation of thioglycollate. Also, these E-
seiectin deficient mice appear to develop normally but may have mildly elevated 
numbers of neutrophils in the peripheral circulation. 
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GENERAL DISCUSSION AND SUMMARY 
This work represents a portion of a comprehensive evaluation of the role of 
E-selectin In murine Inflammation which was conducted by the adhesion molecule 
team at Hoffmann-La Roche, Inc., Nutley, NJ using novel and unique reagents and 
animal systems. 
The results obtained from these studies were somewhat surprising in that 
work in rats and primates has demonstrated a clear role for E-selectin in acute 
inflammation (238, 240). In contrast, the present studies were unable to 
demonstrate a role for E-selectin that could be separated from that of another 
member of the selectin family, P-selectin. Blocking E-selectin did not decrease the 
neutrophil count in the peritoneal lavage of mice following IP thioglycollate at 3, 4, 
or 6 hours post-treatment nor did it block neutrophil influx into the lungs following 
IN LPS at 2 hours post-treatment. However, in the IN LPS model at 6 hours post-
treatment, E-selectin blocking was only highly significant in the presence of 
blocking antibodies to P-selectin. Work by colleagues at Hoffmann-La Roche have 
supported these findings in mice. It has been demonstrated that IV administration 
of the combination of anti-E- and -P-selectin MAb resulted in a highly significant 
blockade of neutrophils into the peritoneal cavity at 4, 6, and 8 hours after IP 
injection of thioglycollate broth or Sephadex beads (K. Mclntyre, unpublished 
data); however, neither of these models was blocked by anti-E-selectin alone. 
Similarly, in delayed-type hypersensitivity studies in mice, it was shown that anti-E-
and P-selectin MAbs together (but neither MAb alone) were able to block edema 
and neutrophil infiltration in the ears of mice (P. Will, unpublished data). 
The general conclusion from these experiments is that in several models of 
inflammation involving multiple tissues, murine E-selectin and P-selectin appear to 
have overlapping or redundant roles. P-selectIn, alone, is Important in the first 1-2 
hours of an inflammatory response as demonstrated in this work and others (135). 
However, the P-selectin-dependent phase is followed by a phase in which 
neutrophil influx involves both E- and P-selectin. Thus, both molecules can mediate 
the influx of neutrophils into the area of inflammation, suggesting that blocking of 
both molecules is necessary to decrease neutrophil influx. In light of this work, 
antagonists should be directed at the common carbohydrate ligand of the selectins 
rather than either of the selectins present on activated endothelial cells. However, 
this work has also demonstrated that a soluble carbohydrate, acid Le*, was not 
effective in vivo as an antagonist of the selectin-mediated extravasation of 
neutrophils. Synthetic sLe* analogs, or mimetics having higher avidity, will be 
needed if the selectins are to be a realistic target for anti-inflammatory therapies. 
103 
LITERATURE CITED 
1. Cotran RS, Kumar V, Robbins SL Robbing Pathological Basis of Disease. 
4th ed. Philadelphia: W. B. Saunders, 1989; 39-70. 
2. Weiss SJ. Tissue destruction by neutrophils. NEJM 1989; 320:365-376. 
3. Bevilaqua MP. Endothelial-leukocyte adhesion molecules. Annu Rev 
Immunol 1993; 11:767-804. 
4. Paulson JC. Selectin/carbohydrate-mediated adhesion of leukocytes. In: 
Harlan JM, Liu DY, eds. Adhesion, Its Role in Inflammatory Disease. New 
York: W. H. Freeman, 1992; 19-38. 
5. Bevilaqua MP, Nelson RM. Selectins. J Clin Invest 1993; 91:379-387. 
6. Harlan JM, Winn RK, Vedder NB, Doerschuk CM, Rice CL. In vivo models of 
leukocyte adherence to endothelium. In: Harlan JM, Liu DY, eds. 
Adhesion, Its Role in Inflammatory Disease. New York: W. H. Freeman, 
1992; 117-144. 
7. Quie PG. Neutrophil dysfunction and recurrent infection In: Gallin JL, Fauci 
AS,eds. Advances in host defense mechanisms. Phagocytic cells. New 
York: Raven, 1982; 163-185. 
8. Repine JE, Beehler CJ. Neutrophils and adult respiratory distress syndrome: 
two interlocking perspectives in 1991. Am Rev Resp Dis 1991; 144:251-
252. 
9. Weissmann G, Korchak H. Rheumatoid arthritis. The role of neutrophil 
activation. Inflammation 1984; 8:S3-S14. 
10. Lefer DJ, Shandelya SML, Serrano, Jr CV, Becker LC, Kuppusamy P, 
Zweier JL. Cardioprotective actions of a monoclonal antibody against CD-
18 in myocardial ischemia-reperfusion injury. Circulation 1993; 88:1779-
1787. 
104 
11. Langdale LA, Flaherty LC, Liggitt HD, Harlan JM, Rice CL, Winn RK. 
Neutrophils contribute to hepatic ischemia-reperfusion injury by a GDIs-
independent mechanism. J Leukoc Biol 1993; 53:511-517. 
12. Malech HL, Gallin JL Neutrophils in human diseases. NEJM 1987; 317:687-
694. 
13. Varani J, Ginsberg I, Schuger L, Gibbs DF, Bromberg J, Johnson KJ, Ryan 
US, Ward PA. Endothelial cell killing by neutrophils. Synergistic 
interaction of oxygen products and proteases. Am J Pathol 1989; 135:435-
438. 
14. McPhail LC, Dechatelet LR, Shirley PS. Further characterization of NADPH 
oxidase activity of human polymorphonuclear leukocytes. J Clin Invest 
1976; 58:775-780. 
15. Martin WJ II. Neutrophils kill pulmonary endothelial cells by a hydrogen 
peroxide-dependent pathway. An in vitro model of neutrophil-mediated 
lung injury. Am Rev Resp Dis 1984; 130:209-213. 
16. Varani J, Fligiel SEG, Till GO, Kunkel RG, Ryan US, Ward PA. Pulmonary 
endothelial cell killing by human neutrophils: possible involvement of 
hydroxyl radical. Am Rev Resp Dis 1985; 53:656-663. 
17. Test ST, Weiss SJ. The generation and utilization of chlorinated oxidants by 
human neutrophils. Adv Free Radical Biol Med 1986; 2:91-116. 
18. Travis J, Salvesen GS. Human plasma proteinase inhibitors. Ann Rev 
Biochem 1983; 52:655-709. 
19. Janoff A. Elastase in tissue injury. Annu Rev Med 1985; 36:207-216. 
20. Smedly LA, Tonnesen MG, Sandhaus RA, Haslett C, Guthrie LA, Johnston, 
Jr RB, Henson PM, Worthen GS. Neutrophil-mediated injury to endothelial 
cells. Enhancement by endotoxin and essential role of neutrophil 
elastase. J Clin Invest 1986; 77:1233-1243. 
105 
21. Westlin WF, Gimbrone MAJ. Neutrophil-mediated damage to human 
vascular endothelium. Role of cytokine activation. Am J Pathol 1993; 
142:117-128. 
22. Harlan JM, Killen PD, Harker LA, Striker GE, Wright DG. Neutrophil-
mediated endothelial injury in vitro. Mechanisms of cell detachment. J Clin 
Invest 1981; 68:1394-1400. 
23. Anderson BO, Brown JM, Bensard DD, Grossol MA, Banerjee A, Patt A, 
Whitman GJR, Harken AH. Reversible lung neutrophil accumulation can 
cause injury by elastase-mediated mechanisms. Surgery 1990; 108:262-
268. 
24. Ossanna PJ, Test SJ, Matheson NR, Regiani S, Weiss SJ. Oxidative 
regulation of neutrophil elastase/alpha-1-proteinase inhibitor interactions. 
J Clin Invest 1986; 77:1939-1951. 
25. Matheson NR, Wong PS, Schuyler M, Travis J. Interaction of human a-1-
proteinase Inhibitor with neutrophil myeloperoxidase. Biochem 1981; 
20:331-336. 
26. Colditz IG. Margination and emigration of leucocytes. Surv Synth Path Res 
1985; 4:44-68. 
27. Hesslon C, Osborn L, Goff D, Chi-Rosso G, Vassallo C, Pasek M, Pittack C, 
Tizard R, Goelz S, McCarthy K, Hopple S, Lobb R. Endothelial leukocyte 
adhesion molecule 1: direct expression cloning and functional 
interactions. Proc Natl Acad Sci USA 1990; 87:1673-1677. 
28. Gimbrone MA Jr, Brock AF, Schafer AI. Leukotriene B4 stimulates 
polymorphonuclear leukocyte adhesion to cultured vascular endothelial 
cells. J Clin Invest 1984; 74:1552-1555. 
29. Tonnesen MG, Smedly LA, Henson PM. Neutrophil-endothelial ceil 
interactions. Modulation of neutrophil adhesiveness induced by 
complement fragment C5a and C5a des arg and formyl-methionyi-leucyl-
phenyalanine in vitro. J Clin Invest 1984; 74:1581-1592. 
106 
30. Lawrence MB, Smith CW, Esl<in SG, IVIclntIre LV. Effect of venous shear 
stress on CD18-mediated neutrophil adhesion to cultured endothelium. 
Blood 1990: 75:227-237. 
31. Kishimoto TK. A dynamic model for neutrophil localization to inflammatory 
sites. J of NIH Res 1991; 3:75-77. 
32. Butcher EC. Leukocyte-endothelial cell recognition: three (or more) steps to 
specificity and diversity. Cell 1991; 67:1033-1036. 
33. Lawrence MB, Springer TA. Leukocytes roll on a selectin at physiologic flow 
rates: distinction from and prerequisite for adhesion through integrins. Cell 
1991; 65:859-873. 
34. Atherton A, Born GVR. Quantitative investigations of the adhesiveness of 
circulating polymorphonuclear leukocytes to blood vessel walls. J Physiol 
1972; 222:447-474. 
35. Atherton A, Born GVR. Relationship between the velocity of rolling 
granulocytes and that of the blood flow in venules. J Physiol 1973; 
233:157-165. 
36. Schmid-Schoenbein GW, Fung Y-C, Zweifach BW. Vascular endothelium-
leukocyte interaction. Sticking shear force in venules. Circ Res 1975; 
36:173-184. 
37. Larson RS, Springer TA. Structure and function of leukocyte integrins. 
Immunol Revs 1990; 114:181-217. 
38. Kishimoto TK, Jutila MA, Berg EL, Butcher EC. Neutrophil Mac-1 and MEL-
14 adhesion proteins inversely regulated by chemotactic factors. Science 
1989; 245:1238-1241. 
39. Bienvenu K, Hernandez L, Granger DN. Leukocyte adhesion and emigration 
in inflammation. Ann N Y Acad Sci 1992; 664:388-399. 
40. Williams TJ, Hellewell PG. Endothelial ceil biology. Adhesion molecules 
involved in the microvascular inflammatory response. Am Rev Respir Dis 
1992; 146:S45-S50. 
107 
41. Carlos TM, Harlan JM. Membrane proteins involved in phagocyte adherence 
to endothelium. Immunol Rev 1990; 114:5-28. 
42. Anderson DC, Springer TA. Leukocyte adhesion deficiency: an inherited 
defect in the Mac-1, LFA-1, and pi 50,95 glycoproteins. Ann Rev Med 
1987; 38:175-194. 
43. Smith CW, Marlin SD, Rothlein R, Toman C, Anderson DA. Cooperative 
interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in 
facilitating adherence and transendothelial migration of human 
neutrophils in vitro. J Clin Invest 1989; 83:2008-2017. 
44. Lo SK, van Seventer GA, Levin SM, Wright SD. Two leukocyte receptors 
(CD11a/CD18 and CD1 lb/CD 18) mediate transient adhesion to 
endothelium by binding to different ligands. J Immunol 1989; 143:3325-
3329. 
45. Lobb RR. Integrin-immunoglobulin superfamily interactions in endothelial-
leukocyte adhesion. Adhesion: its role in inflammatory disease, Harlan 
and Liu, eds 1992; 
46. Vedder NB, Harlan JM. Increased surface expression of CD1 lb/CD 18 (Mac-
1) is not required for stimulated neutrophil adherence to cultured 
endothelium. J Clin Invest 1988; 81:676-682. 
47. N Hogg, J Harvey, C Cabanas, RC Landis. Control of leukocyte integrin 
activation. Am Rev Resp Dis 1993; 148:S55-S59. 
48. Lollo BA, Chan KWH, Hanson EM, Moy VT, Brian AA. Direct evidence for two 
affinity states for lymphocyte function-associated antigen 1 on activated T 
cells. J Biol Chem 1993; 268:21693-21700. 
49. Springer TA. Adhesion receptors of the immune system. Nature 1990; 
346:425-434. 
50. Wilson RW, Ballantyne CM, Smith CW, Montgomery C, Bradley A, O'Brien 
WE, Beaudet AL. Gene targeting yields a CD18-mutant mouse for study of 
inflammation. J Immunol 1993; 151:1571-1578. 
108 
51. Simmons D, Makgoba MW, Seed B. ICAM, an adhesion ligand of LFA-1, is 
homologous to the neural cell adhesion molecule NCAM. Nature 1988; 
331:624-627. 
52. Staunton DE, Dustin ML, Springer TA. Functional cloning of ICAM-2, a cell 
adhesion ligand for LFA-1 homologous to ICAM-1. Nature 1989; 339:61-
64. 
53. Vazeux R, Hoffman PA, Tomita JK, Dickinson ES, Jasman RL, St. John T, 
Gallatin WM. Cloning and characterization of a new intercellular adhesion 
molecule ICAM-R. Nature 1992; 360:485-488. 
54. Fawcett J, Holness CLL, Needham LA, Turley H, Gatter KC, Mason DY, 
Simmons DL. Molecular cloning of ICAM-3, a third ligand for LFA-1, 
constitutively expressed on resting leukocytes. Nature 1992; 360:481-484. 
55. Osborn L, Hession C, Tizard R, Vassallo C, Luhowskyj S, Chi-Rosso G, Lobb 
R. Direct expression cloning of vascular cell adhesion molecule 1, a 
cytokine-induced endothelial protein that binds to lymphocytes. Ceil 1989; 
59:1203-1211. 
56. Elices MJ, Osborn L, Takada Y, Crouse C, Luhowskyj S, Helmer ME, Lobb 
RR. VCAM-1 on activated endothelium interacts with the leukocyte integrin 
VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 1990; 
60:577-584. 
57. Ruoslahti E. Integrins. J Clin Invest 1991; 87:1-5. 
58. Hem 1er ME. VLA proteins in the integrin family: structures, functions, and 
their role on leukocytes. Ann Rev Immunol 1990; 8:365-400. 
59. Rothlein R, Dustin ML, Marlin SD, Springer TA. A human intercellular 
adhesion molecule (ICAM-1) distinct from LFA-1. J Immunol 1986; 
137:1270-1274. 
60. Marlin SD, Springer TA. Purified intercellular adhesion molecule-1 (ICAM-1) 
is a ligand for lymphocyte function-associated antigen-1 (LFA-1). Cell 
1987; 51:813-819. 
109 
61. de Fougerolles AR, Stacker SA, Schwarting R, Springer TA. 
Characterization of ICAM-2 and evidence for a third counter-receptor for 
LFA-1. J Exp Med 1991; 174:253-267. 
62. de Fougerolles AR, Klickstein LB, Springer TA. Cloning and expression of 
intercellular adhesion molecule 3 reveals strong homology to other 
immunoglobulin family counter-receptors for lymphocyte function-
associated antigen 1. J Exp Med 1993; 177:1187-1192. 
63. Staunton DE, Dustin ML, Erickson HP, Springer TA. The arrangement of the 
Immunoglobulin-like domains of ICAM-1 and the binding sites for LFA-1 
and rhinovirus. Cell 1990; 61:243-254. 
64. Dustin ML, Rothlein R, Shan AK, DInarello CA, Springer TA. Induction by IL-
1 and interferon-y; tissue distribution, biochemistry, and function of a 
natural adherence molecule (ICAM-1). J Immunol 1986; 137:245-254. 
65. Pober JS, Gimbrone MA Jr, Lapierre LA, Mendrick DL, Fiers W, R Rothlein R, 
Springer TA. Overlapping patterns of activation of human endothelial cells 
by interleukin 1, tumor necrosis factor, and immune interferon. J Immunol 
1986; 137:1893-1896. 
66. Smith CW, Rothlein R, Hughes BJ, Mariscaico MM, Rudloff HE, Schmalstieg 
FC, Anderson DC. Recognition of an endothelial determinant for CD18-
dependent human neutrophil adherence and transendothelial migration. J 
Clin Invest 1988; 82:1746-1756. 
67. Diamond ME, Staunton DE, de Fougerolles AR, Stacker SA, Garcia-Agullar 
J, Hibbs ML, Springer TA. ICAM-1 (CD54): a counter-receptor for Mac-1 
(CD11b/CD18). J Cell Biol 1990; 111:3129-3139. 
68. Sligh JEJ, Ballantyne CM, Rich SR, Hawkins HK, Smith CW, Bradley A, 
Beaudet AL. Inflammatory and immune responses are impaired in mice 
deficient in intercellular adhesion molecule 1. Proc Natl Acad Sci USA 
1993; 90:8529-8533. 
110 
69. Barton RW, Rothlein R, Ksiazek J, Kennnedy C. The effect of anti-
intercellular adhesion molecule-1 on phorbol-ester-induced rabbit lung 
inflammation. J Immunol 1989; 143:1278-1282. 
70. Ma X, Lefer DJ, Lefer AM, Rothlein R. Coronary endothelial and cardiac 
protective effects of a monoclonal antibody to intercellular adhesion 
molecule-1 in myocardial ischemia and reperfusion. Circulation 1992; 
86:937-946. 
71. Cosimi AB, Conti D, Delmonico FL, Preffer Fl, Wee S-L, Rothlein R, Faanes 
R, Colvin RB. In vivo effects of monoclonal antibody to ICAM-1 (CD54) in 
nonhuman primates with renal allografts. J Immunol 1990; 144:4604-
4612. 
72. Wegner CD, Gundel RH, Reilly P, N Haynes N, Letts LG, Rothlein R. 
Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of 
asthma. Science 1990; 247:456-459. 
73. Granger DN, Russell J, Arfors KE, Rothlein R, Anderson DC. Role of 
CD11/CD18 and ICAM-1 in ischemia-reperfusion induced leukocyte 
adherence and emigration in mesenteric venules. FASEB J 1991; 
5:A1753. 
74. Nortamo P, Salcedo R, Timonen T, Patarroyo M, Gahmberg CG. A 
monoclonal antibody to the human leukocyte adhesion molecule 
intercellular adhesion molecule-2. Cellular distribution and molecular 
characterization of the antigen. J Immunol 1991; 146:2530-2535. 
75. de Fougerolles AR, Springer TA. Intercellular adhesion molecule 3, a third 
adhesion counter-receptor for lymphocyte function-associated molecule 1 
on resting lymphocytes. J Exp Med 1992; 175:185-190. 
76. Acevedo A, del Pozo MA, Arroyo AG, Sanchez-Mateos P, Gonzalez-Armaro 
R, Sanchez-Mateos F. Distribution of ICAM-3 bearing cells in normal 
human tissues. Expression of a novel counter-receptor for LFA-1 in 
epidermal Langerhans cells. Am J Pathol 1993; 143:774-783. 
111 
77. Bevilaqua MP, Stengelin S, Gimbrone MA Jr, Seed B. Endothelial leukocyte 
adhesion molecule 1: an inducible receptor for neutrophils related to 
complement regulatory proteins and lectins. Science 1989; 243:1160-
1165. 
78. Siegelman MH, van de Rijn M, Weissman IL Mouse lymph node homing 
receptor cDNA clone encodes a glycoprotein revealing tandem interaction 
domains. Science 1989; 243:1165-1172. 
79. Lasky LA, Singer MS, Yednock TA, Dowbenko D, Fennle C, Rodriguez H, 
Nguyen T, Stachel S, Rosen SD. Cloning of a lymphocyte homing 
receptor reveals a lectin domain. Cell 1989; 56:1045-1055. 
80. Johnston Gl, Cook RG, McEver RP. Cloning of GMP-140, a granule 
membrane protein of platelets and endothelium: sequence similarity to 
proteins Involved in cell adhesion and inflammation. Cell 1989; 56:1033-
1044. 
81. Walz G, Aruffo A, Kolanus W, Bevilaqua M, Seed B. Recognition by ELAM-1 
of the sialyl-Le* determinant on myeloid and tumor cells. Science 1990; 
250:1132-1135. 
82. Erbe DV, Wolitzky BA, Presta LG, Norton CR, Ramos RJ, Burns DK, 
Rumberger JM, Rao BNN, Foxall C, Brandley BK, Lasky LA. Identification 
of an E-selectin region critical for carbohydrate recognition and cell 
adhesion. J Cell Biol 1992; 119:215-227. 
83. Erbe DV, Watson SR, Presta LG, Wolitzky BA, Foxall C, Brandley BK, Lasky 
LA. P- and E-selectin use common sites for carbohydrate ligand 
recognition and cell adhesion. J Cell Biol 1993; 120:1227-1235. 
84. Bowen BR, Fennie C, Lasky LA. The Mel 14 antibody binds to the lectin 
domain of the murine peripheral lymph node homing receptor. J Cell Biol 
1990; 110:147-153. 
85. Kansas GS, Spertini O, Stoolman LM, Tedder TF. Molecular mapping of 
functional domains of the leukocyte receptor for endothelium, LAM1. J 
Cell Biol 1991; 114:351-358. 
112 
86. Watson SR, Imai Y, Fennie C, Geoffrey J, Singer M, Rosen SD, Lasky LA. 
The complement binding-like domains of the murine homing receptor 
facilitate lectin activity. J Cell Biol 1991; 115:235-243. 
87. Geng J-G, Moore KL, Johnson AE, McEver RP. Neutrophil recognition 
requires a Ca^^-induced conformational change in the lectin domain of 
GMP-140. J Biol Chem 1991; 226:22313-22318. 
88. Geng J-G, Heavner GA, McEver RP. Lectin domain peptides from selectins 
interact with both cell surface ligands and Ca^+ ions. J Biol Chem 1992; 
267:19846-19853. 
89. Pigott R, Needham LA, Edwards RM, Walker C, Power C. Structural and 
functional studies of the endothelial activation antigen endothelial 
leukocyte adhesion molecule-1 using a panel of monoclonal antibodies. J 
Immunol 1991; 147:130-135. 
90. Johnston Gl, Kurosky A, McEver RP. Structural and biosynthetic studies of 
the granule membrane protein, GMP-140, from human platelets and 
endothelial cells. J Biol Chem 1989; 264:1816-1823. 
91. Johnston Gl, Bliss GA, Newman PJ, McEver RP. Structure of the human 
gene encoding granule membrane protein-140, a member of the selectin 
family of adhesion receptors for leukocytes. J Biol Chem 1990; 
265:21381-21385. 
92. Bevilaqua M, Butcher E, Furie B, Furie BC, Gallatin M, Gimbrone M, Harlan 
J, Kishimoto K, Lasky L, McEver R, Paulson J, Rosen S, Seed B, 
Siegelman M, Springer T, Stoolman L, Tedder T, Varki A, Wagner D, 
Weissman I, Zimmerman G. Selectins: a family of adhesion receptors. Cell 
1991; 67:233. 
93. Collins T, Williams A, Johnston Gl, Kim J, Eddy R, Shows T, Gimbrone MA Jr, 
Bevilaqua MP. Structure and chromosomal location of the gene for 
endothelial-leukocyte adhesion molecule 1. J Biol Chem 1991; 266:2466-
2473. 
113 
94. Dowbenko DJ, Diep A, Taylor BA, Lusis AJ, Lasky LA. Characterization of 
the murine homing receptor gene reveals correspondence between 
protein domains and coding exons. Genomics 1991; 9:270-277. 
95. Ord DC, Ernst TJ, Zhou L-J, Rambaldi A, Spertini O, Griffin J, Tedder TF. 
Structure of the gene encoding the human leukocyte adhesion molecule-
1 (TQ1, Leu-8) of lymphocytes and neutrophils. J Biol Chem 1990; 
265:7760-7767. 
96. McEver RP. Leukocyte interactions mediated by selectins. Thromb 
Haemostasis 1991; 66:80-87. 
97. Lasky LA. Selectins: interpreters of cell-specific carbohydrate information 
during inflammation. Science 1992; 258:964-969. 
98. Tedder TF, Isaacs CM, Ernst TJ, Demetri GD, AdIer DA, Disteche CM. 
Isolation and chromosomal localization of cDNAs encoding a novel 
human lymphocyte cell surface molecule, LAM-1. J Exp Med 1989; 
170:123-133. 
99. Johnston Gl, Le Beau MM, Lemons RS, McEver RP. Cloning of GMP-140: 
chromosomal localization, molecular heterogeneity and identification of 
cDNAs predicting both membrane bound and soluble proteins. Blood 
1988; 72:327a. 
100. Watson ML, KIngsmore SF, Johnston Gl, Siegelman MH, Le Beau MM, 
Lemons RS, Bora NS, Howard TA, Weissman IL, McEver RP, Seldin MF. 
Genomic organization of the selectin family of leukocyte adhesion 
molecules on human and mouse chromosome 1. J Exp Med 1990; 
172:263-272. 
101. KIngsmore SF, Vik DP, Kurtz CB, Leroy P, Tack BF, Weis JH, Seldin MF. 
Genetic organization of complement receptor-related genes in the mouse. 
J Exp Med 1989; 169:1479-1484. 
102. Gallatin WM, Weissman IL, Butcher EC. A cell-surface molecule involved in 
organ-specific homing of lymphocytes. Nature 1983; 304:30-34. 
114 
103. Mountz JD, Gause WC, Finkelman FD, Steinberg AD. Prevention of 
lymphadenopathy in IVIRL-ipr/ipr mice by blocking peripheral lymph node 
homing with Mel-14 in vivo. J Immunol 1988; 140:2943-2949. 
104. Gatenby PA, Kansas GS, Xian CY, Evans RL, Engelman EG. Dissection of 
immunoregulatory subpopulations of T lymphocytes within the helper and 
suppressor sublineages in man. J Immunol 1982; 129:1997-2000. 
105. Camerini D, James SP, Stamenkovic I, Seed B. Leu-8/TQ1 is the human 
equivalent of the Mel-14 lymph node homing receptor. Nature 1989; 
342:78-82. 
106. Griffin JD, Spertini O, Ernst TJ, Belvin MP, Levine HB, Kanakura Y, Tedder 
TF. Granulocyte-macrophage colony-stimulating factor and other 
cytokines regulate surface expression of the leukocyte adhesion 
molecule-1 on human neutrophils, monocytes, and their precursors. J 
Immunol 1990; 145:576-584. 
107. Hallmann R, Jutlla MA, Smith CW, Anderson DC, Kishlmoto TK, Butcher EC. 
The peripheral lymph node homing receptor, LECAM-1 is involved in 
CD18-independent adhesion of human neutrophils to endothelium. 
Biochem Biophys Res Comm 1991; 174:236-243. 
108. Tedder TF, Penta AC, Levine HB, Freedman AS. Expression of the human 
leukocyte adhesion molecule LAM1. Identity with the TQ1 and Leu-8 
differentiation antigens. J Immunol 1990; 144:532-540. 
109. Lewinsohn DM, Bargatze RF, Butcher EC. Leukocyte-endothelial cell 
recognition: evidence of a common molecular mechanism shared by 
neutrophils, lymphocytes, and other leukocytes. J Immunol 1987; 
138:4313-4321. 
110. Jutila MA, Rott L, Berg EL, Butcher EC. Function and regulation of the 
neutrophil MEL-14 antigen in vivo: comparison with LFA-1 and MAC-1. J 
Immunol 1989; 143:3318-3324. 
111. Jung TM, Gallatin WM, Weissman IL, Dailey MO. Down regulation of homing 
receptors after T cell activation. J Immunol 1988; 141:4110-4117. 
115 
112. Berg M, James SP. Human neutrophils release the Leu-8 lymph node 
homing receptor during cell activation. Blood 1990; 76:2381-2388. 
113. Tedder TF. Cell-surface receptor shedding: a means for regulating function. 
Am J Respir Cell Mol Biol 1991; 5:305-306. 
114. Watson SR, Fennie C, Lasky LA. Neutrophil influx into an inflammatory site 
inhibited by a soluble homing receptor-IgG chimaera. Nature 1991; 
349:164-167. 
115. Ley K, Gaehtgens P, Fennie C, Singer MS, Lasky LA, Rosen SD. Lectin-like 
cell adhesion molecule 1 mediates leukocyte rolling in mesenteric 
venules in vivo. Blood 1991; 77:2553-2555. 
116. Kishimoto TK, Warnock RA, Jutila MA, Butcher EC, Lane C, Anderson DC, 
Sinith CW. Antibodies against human neutrophil LECAM-1 (LAM-1/Leu-
8/DREG-56 antigen) and endothelial cell ELAM-1 inhibit a common 
CD18-independent adhesion pathway in vitro. Blood 1991; 78:805-811. 
117. Spertini O, Luscinskas FW, Kansas GS, Glmbrone MA Jr, Tedder TF. 
Leukocyte adhesion molecule-1 (LAM-1, L-selectin) interacts with an 
inducible endothelial cell ligand to support leukocyte adhesion. J Immunol 
1991; 147:1565-1573, 
118. Spertini O, Luscinkas FW, Gimbrone, MA Jr, Tedder TF. Monocyte 
attachment to activated human vascular endothelium in vitro is mediated 
by leukocyte adhesion molecule-1 (L-selectin). J Exp Med 1992; 
175:1789-1792. 
119. Spertini O, Kansas GS, Munro JM, Griffin JD, Tedder TF. Regulation of 
leukocyte migration by activation of the leukocyte adhesion molecule-1 
(LAM-1) selectin. Nature 1991; 349:691-694. 
120. Israels SJ, Gerrard JM, Jacques YV, McNicol A, Cham B, Nishibori M, 
Sainton DF. Platelet dense granule membranes contain both 
granulophisin and P-selectin. Blood 1992; 80:143-152. 
116 
121. Bonfanti R, Furie BC, Furie B, Wagner DD. PADGEM (GIVIP140) is a 
component of Weibel-Palade bodies of human endothelial cells. Blood 
1989; 73:1109-1112. 
122. McEver RP, Beckstead JH, Moore KL, Marshall-Carlson L, Sainton DF. GMP-
140, a platelet alpha-granule membrane protein, is also synthesized by 
vascular endothelial cells and Is located in Weibel-Palade bodies. J Clin 
Invest 1989; 84:92-99. 
123. Stenberg PE, McEver RP, Shuman MA, Jacques YV, Bainton DF. A platelet 
alpha-granule membrane protein (GMP-140) is expressed on the plasma 
membrane after activation. J Cell Biol 1985; 101:880-886. 
124. Hsu-Lin SC, Berman CL, Furie BC, August D, Furie B. A platelet membrane 
protein expressed during platelet activation and secretion: studies using a 
monoclonal antibody specific for thrombin-activated platelets. J Biol Chem 
1984; 259:9121-9126. 
125. Hattori R, Hamilton KK, Fugate RD, McEver RP, Sims PJ. Stimulated 
secretion of endothelial von Willebrand Factor Is accompanied by rapid 
redistribution to the cell surface of the intracellular granule membrane 
protein GMP-140. J Biol Chem 1989; 264:7768-7771. 
126. Hamburger SA, McEver RP. GMP-140 mediates adhesion of stimulated 
platelets to neutrophils. Blood 1990; 75:550-554. 
127. Geng JG, Bevilaqua MP, Moore KL, Mclntyre TM, Prescott SM, Kim JM, Bliss 
GA, Zimmerman GA, McEver RP. Rapid neutrophil adhesion to activated 
endothelium mediated by GMP-140. Nature 1990; 343:757-760. 
128. Larsen E, Cell A, Gilbert GE, Furie BC, Erban JK, Bonfanti R, Wagner DD, 
Furie B. PADGEM protein, a receptor that mediates the interaction of 
activated platelets with neutrophils and monocytes. Cell 1989; 59:305-
312. 
129. de Bruijne-Admiraal LG, Modderman PW, Von dem Borne AEGK, 
Sonnenberg A. P-selectin mediates Ca2+-dependent adhesion of 
117 
activated plateiets to many different types of leul<ocytes: detection by fiow 
cytometry. Blood 1992; 80:134-142. 
130. Patel KD, Zimmerman GA, Prescott SM, McEver RP, Mclntyre TM. Oxygen 
radicals induce human endothelial cells to express GMP-140 and bind 
neutrophils. J Cell Biol 1991; 112:749-759. 
131. Weller A, fsenmann S, Vestweber D. Cloning of the mouse endothelial 
selectins: Expression of both E- and P-selectin is inducible by tumor 
necrosis factor a. J Biol Chem 1992; 267:15176-15183. 
132. Manning AM, Kukielka GL, Dore M, Hawkins HK, Sanders WE, Michael LH, 
Entman ML, Smith CW, Anderson DC. Regulation of GMP-140 mRNA in a 
canine model of inflammation. FASEB J 1992; 6:1060A. 
133. Sanders WE, Wilson RW, Ballantyne CM, Beaudet AL Molecular cloning 
and analysis of in vivo expression of murine P-selectin. Blood 1992; 
80:795-800. 
134. Subramaniam M, Koedam JA, Wagner DD. Divergent fates of P- and E-
selectins after their expression on the plasma membrane. Molec Biol Cell 
1993; 4:791-801. 
135. Mayadas TN, Johnson RC, Rayburn H, Hynes RO, Wagner DD. Leukocyte 
rolling and extravasation are severely compromised in P seiectin-deficient 
mice. Ceil 1993; 74:541-554. 
136. Bevilaqua MP, Pober JS, Mendrick DL, Cotran RS, Gimbrone MA Jr. 
identification of an inducible endothelial-leukocyte adhesion molecule. 
Proc Natl Acad Sci USA 1987; 84:9238-9242. 
137. von Asmuth EJU, CJ van der Linden, JFM Leeuwenberg, WA Buurman. 
Involvement of the CD11b/CD18 integrin, but not of the endothelial cell 
adhesion molecules ELAM-1 and ICAM-1 in tumor necrosis factor-a-
induced neutrophil toxicity. J Immunol December 1, 1991; 147:3869-3875. 
138. Matis WL, RM Lavker RM, GF Murphy GF. Substance P induces the 
expression of an endothelial-leukocyte adhesion molecule by 
microvascular endothelium. J Invest Dermatol 1990; 94:492-495. 
118 
139. Whelan J, Ghersa P, van Huijsduijnen RH, Gray J, Chandra G, Talabot F, 
DeLamarter JF. An NFKB-like factor is essential but not sufficient for 
cytokine induction of endothelial leukocyte adhesion molecule 1 (EI_AIVI-
1) gene transcription. NucI Acids Res 1991; 19:2645-2653. 
140. Leeuwenberg JFM, von Asmuth EJU, Jeunhomme TMAA, Buurman WA. 
IFN-g regulates the expression of the adhesion molecule ELAM-1 and IL-
6 production by human endothelial cells in vitro. J Immunol 1990; 
145:2110-2114. 
141. Ooukas J, Pober JS. IFN-y enhances endothelial activation induced by 
tumor necrosis factor but not IL-1. J Immunol 1990; 145:1727-1733. 
142. Pober JS, Slowik MR, De Luca LG, Ritchie AJ. Elevated cyclic AMP inhibits 
endothelial cell synthesis and expression of TNF-induced endothelial 
leukocyte adhesion molecule-1, and vascular cell adhesion molecule-1, 
but not intercellular adhesion molecule-1. J Immunol 1993; 150:5114-
5123. 
143. Pigott R, Dillon LP, Hemingway IK, Gearing AJH. Soluble forms of E-selectin, 
ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated 
cultured endothelial cells. Biochem Biophys Res Comm 1992; 187:584-
589. 
144. Newman W, Beall LD, Carson CW, Hunder GG, Graben N, Randhawa ZI, 
Gopal TV, Wiener-Kronish J, Matthay MA. Soluble E-selectin is found in 
supernatants of activated endothelial cells and is elevated in the serum of 
patients with septic shock. J Immunol 1993; 150:644-654. 
145. Leeuwenberg JFM, Smeets EF, Neefjes JJ, Shaffer MA, Cinek T, 
Jeunhomme TMAA, Ahern TJ, Buurman WA. E-selectin and intercellular 
adhesion molecule-1 are released by activated human endothelial cells in 
vitro. Immunol 1992; 77:543-549. 
146. Engelberts I, Samyo SK, Leeuwenberg JFM, van der Linden CJ, Buurman 
WA. A role for ELAM-1 in the pathogenesis of MOF during septic shock. J 
Surg Res 1992; 53:136-144. 
119 
147. Drake TA, Cheng J, Chang A, Taylor FBJ. Expression of tissue factor, 
thrombomodulin, and E-selectin in baboons with lethal Escherichia coli 
sepsis. Am J Pathol 1993; 142:1458-1470. 
148. Munro JM, Pober JS, Cotran RS. Tumor necrosis factor and interferon-? 
induce distinct patterns of endothelial activation and associated leukocyte 
accumulation in skin of Papio anubis. Am J Pathol 1989; 135:121-133. 
149. Fries JWU, Williams AJ, Atkins RC, Newman W, Lipscomb MF, Collins T. 
Expression of VCAM-1 and E-selectin in an in vivo model of endothelial 
activation. Am J Pathol 1993; 143:725-737. 
150. Munro JM, Pober JS, Cotran RS. Recruitment of neutrophils in the local 
endotoxin response: association with de novo endothelial expression of 
endothelial leukocyte adhesion molecule-1. Lab Invest 1991; 64:295-299. 
151. Ferran C, Peuchmaur M, Desruennes M, Ghoussoub JJ, Cabrol A, Brousse 
N, Cabrol C, Bach JF, Chatenoud L. Implications of de novo ELAM-1 and 
VCAM-1 expression in human cardiac allograft rejection. Transplantation 
1993; 55:605-609: 
152. Leung DYM, Pober JS, Cotran RS. Expression of endothelial-leukocyte 
adhesion molecule-1 in elicited late phase allergic reactions. J Clin Invest 
1991; 87:1805-1809. 
153. Norris P, Poston RN, Thomas DS, Thornhill M, Hawk J, Haskard DO. The 
expression of endothelial leukocyte adhesion molecule-1, intercellular 
adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 
(VCAM-1) in experimental cutaneous inflammation: a comparison of 
ultraviolet B erythema and delayed hypersensitivity. J Invest Dermatol 
1991; 96:763-770. 
154. Sollberg S, Peltonen J, Uitto J, Jimenez SA. Elevated expression of pi and 
P2 integrins, intercellular adhesion molecule 1, and endothelial leukocyte 
adhesion molecule 1 in the skin of patients with systemic sclerosis of 
recent onset. Arthrit Rheumat 1992; 35:290-298. 
120 
155. Norton J, Sloane JP, Delia D, Greaves MF. Reciprocal expression of C034 
and cell adhesion molecule ELAM-1 on vascular endothelium in acute 
cutaneous graft-versus-host disease. J Pathol 1993; 170:173-177. 
156. Koch AE, Burrows JC, Haines GK, Carlos TM, Harlan JM, Leibovich SJ. 
Immunolocalization of endothelial and leukocyte adhesion molecules in 
human rheumatoid and osteoarthritic synovial tissues. Lab Invest 1991; 
64:313-320. 
157. Bochner BS, Luscinskas FW, Gimbrone MA Jr, Newman W, Sterbinsky SA, 
Derse-Anthony CP, Klunk D, Schleimer RP. Adhesion of human 
basophils, eosinophils, and neutrophils to interleukin 1-activated human 
vascular endothelial cells: contributions of endothelial cell adhesion 
molecules. J Exp Med 1991; 173:1553-1556. 
158. Picker LJ, Kishimoto TK, Smith CW, Warnock RA, Butcher EC. ELAM-1 is an 
adhesion molecule for skin-homing T cells. Nature 1991; 349:796-799. 
159. Graber N, Gopal TV, Wilson D, Beall LD, Polte T, Newman W. T cells bind to 
cytokine-activated endothelial cells via a novel, inducible 
sialoglycoprotein and endothelial leukocyte adhesion molecule-1. J 
Immunol 1990; 145:819-830. 
160. Weller PF, Rand TH, Goelz SE, Chi-Rosso G, Lobb RR. Human eosinophil 
adherence to vascular endothelium mediate by binding to vascular cell 
adhesion molecule 1 and endothelial leukocyte adhesion molecule 1. 
Proc Natl Acad Sci USA 1991; 88:7430-7433. 
161. Hakkert BC, Kuijpers TW, Leeuwenberg JFM, van Mourik JA, Ross D. 
Neutrophil and monocyte adherence to and migration across monolayers 
of cytokine-activated endothelial cells: the contribution of GDI 8, ELAM-1, 
and VLA-4. Blood 1991; 78:2721-2726. 
162. Shimizu Y, Shaw S, Graber N, Gopal TV, Horgan KJ, Van Seventer GA, 
Newman W. Activation-independent binding of human memory T cells to 
adhesion molecule ELAM-1. Nature 1991; 349:799-802. 
121 
163. Lo SK, Lee S, Ramos RA, Lobb R, Rosa M, Chi-Rosso G, Wright SD. 
Endothelial-leul<ocyte adhesion molecule 1 stimulates the adhesive 
activity of leukocyte integrin CR3 (CD11b/CD18, Mac-1, amp2) on human 
neutrophils. J Ex IVIed 1991; 173:1493-1500. 
164. Kuijpers TW, Hakkert BC, Hoogenwerf l\^, Leeuwenberg JFM, Roos D. Role 
of endothelial leukocyte adhesion molecule-1 and platelet-activating 
factor in neutrophil adherence to IL-1-prestimulated endothelial cells. 
Endothelial leukocyte adhesion molecule-1 mediated CD 18 activation. J 
Immunol 1991; 147:1369-1376. 
165. Becker-Andre M, van Huijsduijnen RH, Losberger C, Whelan J, Delamarter 
JF. Murine endothelial leukocyte-adhesion molecule 1 is a close structural 
and functional homologue of the human protein. Eur J Biochem 1992; 
206:401-411. 
166. Hooft van Huijsduijnen R, Whelan J, Pescini R, Becker-Andre M, Schenk A-
M, DeLamarter JF. A T-cell enhancer cooperates with NF-KB to yield 
cytokine induction of E-selectin gene transcription in endothelial cells. J 
Biol Chem 1992; 267:22385-22391. 
167. Deisher TA, Sato TT, Pohlman TH, Harlan JM. A protein kinase C 
antagonist, selective for the pi isozyme, induces E-selectin and VCAM-1 
expression on HUVEC but does not translocate PKC. Biochem Biophys 
Res Commun 1993; 193:1283-1290. 
168. Montgomery KF, Osborn L, Hession C, Tizard R, Goff D, Vassallo C, Tarr PI, 
Bomsztyk K, Lobb R, Harlan JM, Pohlman TH. Activation of endothelial-
leukocyte adhesion molecule-1 (ELAM-1) gene transcription. Proc Natl 
Acad Sci USA 1991; 88:6523-6527. 
169. Cronstein BN, Kimmel SC, Levin Rl, Martiniuk F, Weissman G. A mechanism 
for the antiinflammatory effects of corticosteroids: the glucocorticoid 
receptor regulates leukocyte adhesion to endothelial cells and expression 
of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion 
molecule 1. Proc Natl Acad Sci USA 1992; 89:9991-9995. 
122 
170. Selby C, MacNee W. Factors affecting neutropliil transit during acute 
pulmonary inflammation:minireview. Exp Lung Res 1993; 19:407-428. 
171. Katayama M, Handa M, ArakI Y, Ambo H, Kawai Y, Watanabe K, Ikeda Y. 
Soluble P-selectin is present in normal circulation and its plasma level is 
elevated in patients with thrombotic thrombocytopenic purpura and 
haemolytic uraemic syndrome. Brit J Haematol 1993; 84:702-710. 
172. Dunlop LC, Skinner MP, Bendall U, Favaloro EJ, Castaldi PA, Gorman JJ, 
Gamble JR, Vadas MA, Berndt MC. Characterization of GMP-140 (P-
selectin) as a circulating plasma protein. J Exp Med 1992; 175:1147-
1150. 
173. Schleiffenbaum B, Spertini O, Tedder TF. Soluble L-selectin is present in 
human plasma at high levels and retains functional activity. J Cell Biol 
1992; 119:229-238. 
174. Gearing AJH, Newman W. Circulating adhesion molecules in disease. 
Immunol Today 1993; 14:506-512. 
175. Gearing AJH, Hemingway I, Pigott R, Hughes J, Rees AJ, Cashman SJ. 
Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and 
VCAM-1: pathological significance. Ann N Y Acad Sci 1992; 667:324-331. 
176. Spertini O, Schleiffenbaum B, White-Owen C, Ruiz PJ, Tedder TF. ELISA for 
quantitation of L-selectin shed from leukocytes in vivo. J Immunol Meths 
1992; 156:115-123. 
177. Gamble JR, Skinner MP, Berndt MC, Vadas MA. Prevention of activated 
neutrophil adhesion to endothelium by soluble adhesion protein GMP140. 
Science 1990; 249:414-417. 
178. Lobb RR, Chi-Rosso G, Leone DR, Rosa MD, Bixler S, Newman BM, 
Luhowskyj S, Benjamin CD, Douglas IG, Goelz SE, Hession C, Chow EP. 
Expression and functional characterization of a soluble form of 
endothelial-leukocyte adhesion molecule 1. J Immunol 1991; 147:124-
129. 
123 
179. Stoolman LM, Tenforde TS, Rosen SD. Phosphomannosyl receptors may 
participate in the adhesive interaction between lymphocytes and high 
endothelial venules. J Cell Biol 1984; 99:1535-1540. 
180. Yednock YA, Butcher EC, Stoolman LM, Rosen SD. Receptors involved in 
lymphocyte homing: relationship between a carbohydrate-binding 
receptor and the Mel-14 antigen. J Cell Biol 1987; 104:725-731. 
181. Brandley BK, Swiedler SJ, Robblns PW. Carbohydrate ligands of the LEC 
cell adhesion molecules. Cell 1990; 63:861-863. 
182. Varki A. Selectins and other mammalian sialic acid-binding lectins. Curr 
Opin Ceil Biol 1992; 4:257-266. 
183. E Larsen, T Palabrica, S Sajer, GE Gilbert, DD Wagner, BC Furie, B Furie. 
PADGEM-dependent adhesion of platelts to monocytes and neutrophils is 
mediated by a lineage-specific cabohydrate, LNF-III (CD15). Cell 1990; 
63:467-474. 
184. Lowe JB, Stoolman LM, Nair RP, Larsen RD, Berhend TL, Marks RM. ELAM-
1-dependent cell adhesion to vascular endothelium determined by a 
transfected human fucosyltransferase cDNA. Cell 1990; 63:475-484. 
185. Phillips ML, Nudelman E, Gaeta FCA, Perez M, Singhal AK, Hakomori S-l, 
Paulson JC. ELAM-1 mediates cell adhesion by recognition of a 
carbohydrate ligand, sialyi-Le*. Science 1990; 250:1130-1132. 
186. Tiemeyer M, Swiedler SJ, Ishihara M, Moreland M, Schweingruber H, 
Hirtzer P, Brandley BK. Carbohydrate ligands for endotheiiai-leukocyte 
adhesion molecule 1. Proc Natl Acad Sci 1991; 88:1138-1142. 
187. Goelz SE, Hession C, Goff D, Griffiths B, Tizard R, Newman B, Chi-Rosso G, 
Lobb R. ELFT: a gene that directs the expression of an ELAM-1 ligand. 
Ceil 1990; 63:1349-1356. 
188. Zhou Q, Moore KL, Smith DF, Varki A, McEver RP, Cummings RD. The 
selectin GMP-140 binds to siaiylated, fucosylated lactosaminogiycans on 
both myeloid and nonmyeioid cells. J Ceil Biol 1991; 115:557-564. 
124 
189. Polley MJ, Phillips ML, Wayner E, Nudelman E, Singhal AK, Hakomori SI, 
Paulson JC. CD62 and endothelial cell-leukocyte adhesion molecule 
1(ELAM-1) recognize the same carbohydrate ligand, sialyl-Lewis x. Proc 
Natl Acad Sci 1991; 88:6224-6228. 
190. Berg EL, Magnani J, Warnock RA, Robinson MK, Butcher EC. Comparison of 
L-selectin and E-selectin ligand specificities: the L-selectin can bind the E-
selectin ligands sialyl Le* and sialyl Le=. Biochem Biophys Res Commun 
1992; 184:1048-1055. 
191. Foxall C, Watson SR, Dowbenko D, Fennie 0, Lasky LA, Kiso M, Hasegawa 
A, Asa D, Brandley BK. The three members of the selectin receptor family 
recognize a common carbohydrate epitope, the sialyl Lewis x 
oligosaccharide. J Cell Biol 1992; 117:895-902. 
192. Corrall LC, Singer M, Macher B, Rosen SD. Requirements for sialic acid on 
neutrophils in a GMP-140 (PADGEM) mediated adhesive interaction with 
activated platelets. Biochem Biophys Res Comm 1990; 172:1349-1352. 
193. Springer TA, Lasky LA. Sticky sugars for selectins. Nature 1991; 349:196-
197. 
194. Tyrrell D, James P, Rao N, Foxall C, Abbass S, Dasgupta F, Nashed M, 
Hasegawa A, Kiso M, Asa D, Kidd J, Brandley BK. Structural requirements 
for the carbohydrate ligand of E-selectin. Proc Natl Aced Sci USA 1991; 
88:10372-10376. 
195. Berg EL, Robinson MK, Mansson O, Butcher EC, Magnani JL. A 
carbohydrate domain common to both sialyl Le^ and sialyl Le^ is 
recognized by the endothelial cell leukocyte adhesion molecule ELAM-1. 
J Biol Chem 1991; 266:14869-14872. 
196. Handa K, Neudelman ED, Shroud MR, Shiozawa T, Hakomori S. Selectin 
GMP-140 (CD62; PADGEM) binds to sialosyl-Le® and sialosyl-Le*, 
sulfated glycans modulate this binding. Biochem Biophys Res Commun 
1991; 181:1223-1230. 
125 
197. Fukuda M, Spooncer E, Gates JE, Dell A, Klock JC. Structure of the 
slalylated fucosyl lactosaminoglycan isolated from human granulocytes. J 
Biol Chem 1984; 259:10925-10935. 
198. Munro JM, Lo SK, Corless C, Robertson MJ, Lee NC, Barnhill RL, Weinberg 
DS, Bevilaqua MP. Expression of sialyl-Lewis x, an E-selectin ligand, in 
inflammation, immune processes, and lymphoid tissues. Am J Pathol 
1992; 141:1397-1408. 
199. Ghmori K, Yoneda T, Ishihara K, Shigeta K, Hirashlma K, Kanai M, Itai S, 
Sasaoki T, Aril S, Arita H, Kannagi R. Sialyl SSEA-1 antigens as a 
carbohydrate marker of human natural killer cells and immature lymphoid 
cells. Blood 1989; 74:255-261. 
200. Berg EL, Yoshino T, Rott LS, Robinson MK, Warnock RA, Kishimoto TK, 
Picker LJ, Butcher EC. The cutaneous lymphocyte antigen is a skin 
lymphocyte homing receptor for the vascular lectin endothelial cell-
leukocyte adhesion molecule 1. J Exp Med 1991; 174:1461-1468. 
201. Groves RW, Allen MH, Ross EL, Ahsan G, Barker JNWN, MacDonald DM. 
Expression of selectin ligands by cutaneous squamous cell carcinoma. 
Am J Pathol 1993; 143:1220-1225. 
202. Majuri ML, Mattila P, Renkonen R. Recombinant E-selectin-protein mediates 
tumor cell adhesion via sialyl Le^ and sialyl Le*. Biochem Biophys Res 
Commun 1992; 182:1376-1382. 
203. Etzioni A, Frydman M, Pollack S, Avidor I, Phillips ML, Paulson JC, 
Gershoni-Baruch R. Brief report: recurrent severe infections caused by a 
novel leukocyte adhesion deficiency. NEJM 1992; 327:1789-1792. 
204. Imai Y, Lasky LA, Rosen SD. Further characterization of the interaction 
between L-selectin and its endothelial ligand. Glycobiology 1992; 2:373-
381. 
205. Imai Y, Singer MS, Fennie C, Lasky LA, Rosen SD. Identification of a 
carbohydrate-based endothelial ligand for a lymphocyte homing receptor. 
J Cell Biol 1991; 113:1213-1221. 
126 
206. Lasky LA, Singer MS, Dowbenko D, Imai Y, Henzel WJ, Grimley C, Fennie 
C, Gillett N, Watson SR, Rosen SD. An endothelial ligand for L-selectin is 
a novel mucin-like molecule. Cell 1992; 69:927-938. 
207. Moore KL, Stults NL, Diaz S, Smith DF, Cummings RD, Varki A, McEver RP. 
Identification of a specific glycoprotein ligand for P-selectin (CD62) on 
myeloid cells. J Cell Biol 1992; 118:445-456. 
208. Levinovitz A, Muhlhoff J, Isenmann S, Vestweber D. Identification of a 
glycoprotein ligand for E-selectin on mouse myeloid cells. J Cell Biol 
1993; 121:449-458. 
209. Larsen GR, Sako D, Ahern TJ, Shaffer M, Erban J, Sajer SA, Gibson RM, 
Wagner DD, Furie BC, Furie B. P-selectin and E-selectin. Distinct but 
overlapping leukocyte ligand specificities. J Biol Chem 1992; 267:11104-
11110. 
210. von Adrian UH, Chambers JD, McEvoy LM, Bargatze RF, Arfors KE, Butcher 
EC. Two-step model of leukocyte-endothelial cell interactions in 
inflammation: distinct roles for LECAM-1 and the leukocyte P2 integrins in 
vivo. Proc Natl Acad Sci USA 1991; 88:7538-7542. 
211. Smith CW. Transendothelial migration. In: Harlan JM, Liu DY, eds. 
Adhesion, Its Role in Inflammatory Disease. New York: W. H. Freeman, 
1992; 83-107. 
212. Hogg N. Roll, roll, roll your leukocytes gently down the vein. Immunol Today 
1992; 13:113-115. 
213. Tozeren A, Ley K. How do selectins mediate leukocyte rolling in venules. 
Biophys J 1992; 63:700-709. 
214. Ley K, Gaehtgens P. Endothelial, not hemodynamic, differences are 
responsible for preferential leukocyte rolling in rat mesenteric venules. 
Circ Res 1991; 69:1034-1041. 
215. Mayrovitz HN. Leukocyte rolling: a prominent feature of the venules in intact 
skin of anesthetized hairless mice. Am J Physiol 1992; 262:H157-61. 
127 
216. Hammer DA, Apte SM. Simulation of cell rolling and adhesion on surfaces in 
shear flow: general results and analysis of selectin-mediated neutrophil 
adhesion. Biophys J 1992; 63:35-57. 
217. Lawrence MB, Mclntire LV, Eskin SG. Effect of flow on polymorphonuclear 
leukocyte/endothelial cell adhesion. Blood 1987; 70:1284-1290. 
218. von Adrian UH, Hansel! P, Chambers JD, Berger EM, Filho IT, Butcher EC, 
Arfors KE. L-selectin function is required for p2-integrin-mediated 
neutrophil adhesion at physiologic shear rates in vivo. Am J Physiol 1992; 
263: H1034-44. 
219. Fiebig E, Ley K, Arfors KE. Rapid leukocyte accumulation by "spontaneous" 
rolling in and adhesion in the exteriorized rabbit mesentery. Int J 
Microclrc: Clin Exp 1991; 10:127-144. 
220. Thompson PL, Papadimitriou JM, Walters MN-I. Suppression of leucocytic 
sticking and emigration by chelation of calcium. J Pathol Bacteriol 1967; 
94:389-396. 
221. Tangelder G J, Arfors KE. Inhibition of leukocyte rolling in venules by sulfated 
polysaccharides. Federation Proc 1987; 46:1542-1547. 
222. Abbassi O, Lane CL, Krater S, Kishimoto TK, Anderson DC, Mclntyre LV, 
Smith CW. Canine neutrophil margination mediated by lectin adhesion 
molecule-1 in vitro. J Immunol 1991; 147:2107-2115. 
223. Buttrum SM, Hatton R, Nash GB. Selectin-mediated rolling of neutrophils on 
immobilized platelets. Blood 1993; 82:1165-1174. 
224. Jones DA, Abbassi O, Mclntyre LV, McEver RP, Smith CW. P-selectin 
mediates neutrophil rolling on histamine-stimulated endothelial cells. 
Biophys J 1993; 65:1560-1569. 
225. Lawrence MB, Springer TA. Neutrophils roll on E-selectin. J Immunol 1993; 
151:6338-6346. 
226. Smith CW. Endothelial adhesion molecules and their role in inflammation. 
Can J Physiol Pharmacol 1993; 71:76-87. 
128 
227. Picker LJ, Warnock RA, Burns AR, Doerschuk CM, Berg EL, Butcher EC. The 
neutrophil selectin LECAM-1 presents carbohydrate ligands to the 
vascular selectins ELAM-1 and GMP-140. Cell 1991; 66:921-933. 
228. Zimmerman GA, Mclntyre TM, Mehra M, Prescott SM. Endothelial cell-
associated platelet-activating factor: a novel mechanisms for signaling 
intercellular adhesion. J Cell Biol 1990; 110:529-540. 
229. Luscinskas FW, Cybulsky Ml, Kiely J-M, Peckins CS, Davis VM, Gimbrone 
MA Jr. Cytokine-activated human endothelial monolayers support 
enhanced neutrophil transmigration via a mechanism involving both 
endothelial-leukocyte adhesion molecule-1 and intercellular adhesion 
molecule-1. J Immumol 1991; 146:1617-1625. 
230. GO Till, KJ Johnson, R Kunkel, PA Ward. Intravascular activation of 
complement and acute lung injury. J Clin Invest 1982; 69:1126-1135. 
231. Arfors KE, Lundberg C, Lindbom L, Lundberg K, Beatty PG, Harlan JM. A 
monoclonal antibody to the membrane glycoprotein complex CD18 
inhibits polymorphonuclear leukocyte accumulation and plasma leakage 
in vivo. Blood 1987; 69:338-340. 
232. Winn RK, Liggitt D, Vedder NB, Paulson JC, Harlan JM. Anti-P-selectin 
monoclonal antibody attenuates reperfusion injury to the rabbit ear. J Clin 
Invest 1993; 92:2042-2047. 
233. Mulligan MS, Polley MJ, Bauer RJ, Nunn MF, Paulson JC, Ward PA, 
Neutrophil-dependent acute lung injury: requirement for P-selectin (GMP-
140). J Clin Invest 1992; 90:1600-1607. 
234. Mulligan MS, Paulson JC, De Frees S, Zheng Z-L, Lowe JB, Ward PA. 
Protective effects of oligosaccharides in P-selectin-dependent lung injury. 
Nature 1993; 364:149-151. 
235. Mulligan MS, Watson SR, Fennie C, Ward PA. Protective effects of selectin 
chimeras in neutrophil-mediated lung injury. J Immunol 1993; 151:6410-
6417. 
129 
236. Jutila MA, Rott L, Berg EL, Butcher EC. Function and regulation of the 
neutrophil Mel-14 antigen in viva comparison with LFA-1 and Mac-1. J 
Immunol 1989; 143:3318-3324. 
237. Nelson RM, Cecconi O, Roberts WG, Aruffo A, Lindhardt RJ, Bevilaqua MP. 
Heparin oligosaccharides bind L- and P-selectin and inhibit acute 
inflammation. Blood 1993; 82:3253-3258. 
238. Mulligan MS, Varani J, Dame MK, Lane CL, Smith CW, Anderson DC, Ward 
PA. Role of endothelial-leukocyte adhesion molecule-1 (ELAM-1) in 
neutrophil-mediated lung injury in rats. J Clin Invest 1991; 88:1396-1406. 
239. Mulligan MS, Lowe JB, Larsen RD, Paulson J, Zheng Z, DeFrees S, 
Maemura K, Fukuda M, Ward PA. Protective effects of sialylated 
oligosaccharides in immune complex-induced acute lung injury. J Exp 
Med 1993; 178:623-631. 
240. Gundel RH, Wegner CD, Torcellini CA, Clarke CC, Haynes N, Rothlein R, 
Smith CW, Letts LG. Endothelial leukocyte adhesion molecule-1 mediates 
antigen-induced acute airway inflammation and late phase airway 
obstruction in monkeys. J Clin Invest 1991; 88:1407-1411. 
241. Doerschuk CM, Winn RK, Coxson HO, Harlan JM. CD 18-dependent and 
-independent mechanisms of neutrophil emigration in the pumonary and 
systemic microcirculation of rabbits. J Immunol 1990; 144:2327-2333. 
242. Cunningham FM, Smith MJH, Ford-Hutchinson AW, Walker JR. Migration of 
peritoneal polymorphonuclear leukoctyes in the rat. J Pathol 1979; 
128:15. 
243. Snella M-C, Rylander R. Lung cell reactions after inhalation of bacterial 
lipopolysaccharide. Eur J Respir Dis 1982; 63:550-557. 
244. Hudson AR, Kilburn KH, Halprin GM, McKenzie WH. Granulocyte recruitment 
to airways exposed to endotoxin aerosols. Am Rev Resp Dis 1977; 
115:89-95. 
245. Ulich TR, Watson LR, Yin S, Guo K, Wang P, Thang H, del Castillo J. The 
intratracheal administration of endotoxin and cytokines. I. Characterization 
130 
of LPS-induced IL-1 and TNF mRNA expression and the LPS-, IL-1, and 
TNF-induced inflammatory infiltrate. Am J Pathol 1991; 138:1485-1496. 
246. Snella M-C, Rylander R. Lung cell reactions after inhalation of bacterial 
lipopolysaccharide. Eur J Respir Dis 1982; 63: 550-557. 
247. Denis M, Cormier Y, Laviolette M, Ghadlrian E. T cells in hypersensitivity 
pneumonitis: effects of in vivo depletion of T cells in a mouse model. Am J 
Resp Cell Molec Biol 1992; 6:183-189. 
248. Lavi E, Fishman PS, Highkin MK, Weiss SR. Limbic encephalitis after 
inhalation of a murine coronavirus. Lab Invest 1988; 58:31-36. 
249. Knaack P, Reichert J, Harbison M. A comparison of two murine models of 
lipopolysaccharide-induced pulmonary Inflammation. Toxicol Pathol in 
press. 
250. Henderson RF. Use of bronchoalveolar lavage to detect lung damage. In: 
Gardner DE, Crapo JD, Massaro EF, eds. Toxicology of the Lung. New 
York; Raven Press, 1988; 239-268. 
251. Downey GP, Worthen GS, Hensen PM, Hyde DM. Neutrophil sequestration 
and migration in localized pulmonary inflammation. Capillary localization 
and migration across the Interalveolar space. Am Rev Resp Dis 1993; 
147:168-176. 
252. Hattori R, Hamilton KK, McEver RP, Sims PJ. Complement proteins C5b-9 
induce secretion of high molecular weight multimers of endothelial von 
Willebrand factor and translocation of granule membrane protein GMP-
140 to the cell surface. J Biol Chem 1989; 264:9053-9060. 
253. Hahne M, Jager U, Isenmann S, Hallman R, Vestweber D. Five tumor 
necrosis factor-inducible cell adhesion mechanisms on the surface of 
mouse endothelioma cells mediate the binding of leukocytes. J Cell Biol 
1993; 121:655-664. 
254. Redl H, Dinges HP, Buurman WA, van der Linden CJ, Pober JS, Cotran RS, 
Schlag G. Expression of endothelial leukocyte adhesion molecule-1 in 
131 
septic but not traumatic/liypovolemic sliock in tlie baboon. Am J Patlioi 
1991; 139:461-466. 
255. Silber A, Newman W, Reimann KA, Hendricl<s E, Walsh D, Ringler DJ. 
Kinetic expression of endothelial adhesion molecules and relationship to 
leukocyte recruitment in two cutaneous models of inflammation. Lab 
Invest 1994; 70:163-164. 
256. Norton CR, Rumberger JM, Burns DK, Wolitzky BA. Characterization of 
murine E-selectin expression in vitro using novel anti-mouse E-selectin 
monoclonal antibodies. Biochem Biophys Res Commun 1993; 195:250-
258. 
257. Pober JS, Cotran RS. What can be learned from the expression of 
endothelial adhesion molecules in tissues? Lab Invest 1992; 64:301-305. 
258. RodzlnskI E, Burnette WN, Jones T, Mar V, Tuomanen E. Prokaryotic 
peptides that block leukocyte adherence to selectins. J Exp Med 1993; 
178:917-924. 
259. Graves BJ, Crowther RL, Chandran C, Rumberger JM, Li S, Huang K-S, 
Presky DH, Familletti PC, Wolitzky BA, Burns DK. Insight into E-
selectin/ligand interaction from the crystal structure and mutagenesis of 
the lec/EGF domains. Nature 1994; 367:532-538. 
260. Lasky LA. A sweet success. Struct Biol 1994; 1:139-141. 
261. Norgard K. Characterization of a specific ligand for P-selectin on myeloid 
cells. J Biol Chem 1993; 268:12764-12774. 
262. Capecchi MR. Altering the genome by homologous recombination. Science 
1989; 244:1288-1292. 
132 
ACKNOWLEDGEMENTS 
I begin by tlianking Drs. Margaret Harbison, Timothy Anderson, and 
Lawrence Arp. The program which allowed me to do my work in the unique and 
exciting setting of a major pharmaceutical company was their brainchild. Along 
with their acknowledgment, must go one to Dr. Emil Pfitzer, Head of the Department 
of Toxicology and Pathology at Hoffmann-LaRoche, who supported this wonderful 
position. I thank them all. Dr. Harbison has served as my mentor and has been a 
helpful and kind supervisor and deserves an extra thank you. In addition to these 
people at Hoffmann-LaRoche, I thank those back at Iowa State University including 
my POS committee members, Drs. John Kluge (who agreed to be my co-major 
professor when Dr. Arp departed for the East), Ron Myers, Tom Ingebritsen, and 
Don Beitz, and the secretaries in the Department of Pathology. 
A very special thanks goes to my dear friends and ardent supporters, Drs. 
Juan and Ulla Sarmiento. Their encouragement and assistance has been 
invaluable throughout my studies but especially during the writing and assembly of 
the dissertation itself. Thank you, thank you. 
I am also grateful for the advice, assistance, and support of Drs. Kim 
Mclntyre, Carol Meschter, Barry Wolitzky, Dan Burns, Keith Yagaloff, and Mark 
Labow. I can not express enough gratitude to Ms. Janet Reichert for her excellent 
technical assistance and friendship. I also thank Dr. Nancy Everds and the staff in 
the clinical pathology laboratory, Ms. Linda Biagini and the staff in the histology 
laboratory, and the many technicians in the laboratories of Drs. Harbison, Labow, 
Mclntyre, Wolitzky and Yagaloff for their technical assistance. A special thanks 
goes to the following individuals: Janet Becker, Cindy Joskowiak, David Shuster, 
Bob Terry, and Chris Norton. 
133 
Last, but not least, I thank those outside the work environment, namely my 
family and friends. Their support has meant more to me than I can say. I also 
acknowledge my dear companion, Quincy. Although he isn't always patient, he 
has tolerated much. In addition. I thank Dr. Susan Buckley for her guidance and 
support. 
